{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:15:03Z","timestamp":1792422903075,"version":"4.5.0"},"reference-count":374,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-03981-x","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T11:59:57Z","timestamp":1761652797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Biology of stem cell paradox: a double-edged sword-implications for cancer therapy"],"prefix":"10.1186","volume":"25","author":[{"given":"Bemrew Admassu","family":"Mengistu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitayew","family":"Demessie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mebrie Zemene","family":"Kinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalkidan","family":"Getnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abebe Belete","family":"Bitew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassahun","family":"Berrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagaw","family":"Sendeku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asnakew Mulaw","family":"Berihun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anmaw Shite","family":"Abat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsede Solomon","family":"Mebratu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melaku Getahun","family":"Feleke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesibu Tilahun","family":"Yesist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melkamu Molla","family":"Ferede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melkie Dagnaw","family":"Fenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"issue":"3","key":"3981_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3981_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djae321","author":"A Mafra","year":"2024","unstructured":"Mafra A, Laversanne M, Marcos-Gragera R, Chaves HV, Mcshane C, Bray F, et al. The global multiple myeloma incidence and mortality burden in 2022 and predictions for 2045. JNCI J Natl Cancer Inst. 2024. https:\/\/doi.org\/10.1093\/jnci\/djae321.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"3981_CR3","volume-title":"Global cancer observatory: cancer today","author":"J Ferlay","year":"2020","unstructured":"Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pi\u00f1eros M, et al. Global cancer observatory: cancer today. Volume 20182020. Lyon: International agency for research on cancer; 2020."},{"key":"3981_CR4","unstructured":"Organization WH, Cancer Fact SF. 2025, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer 2025."},{"key":"3981_CR5","unstructured":"Society AC. Cancer Facts & Figs. 2025. https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/2025-cancer-facts-figures.html. 2025."},{"key":"3981_CR6","unstructured":"Atlas TC. 4th Edition. Global Cancer Statistics. American Cancer SocietyIARC, June. 2025. https:\/\/pressroom.cancer.org\/2025CancerAtlasReport. 2025."},{"key":"3981_CR7","unstructured":"News A. July. Cancer rates are rising for Generation X and Millennials. What can we do about it? 2025. https:\/\/www.abc.net.au\/news\/2025-07-08\/cancer-early-onset-genx-millennials-screening-prevention\/105495892"},{"key":"3981_CR8","unstructured":"Post TA. Nearly 50% of All Cancer Deaths Worldwide Attributable to Modifiable Risk Factors. July 2025. https:\/\/ascopost.com\/issues\/july-25-2025\/nearly-50-percent-of-all-cancer-deaths-worldwide-attributable-to-modifiable-risk-factors\/.2025."},{"key":"3981_CR9","unstructured":"Health M. Obesity Drives Endometrial Cancer Surge. 2025. https:\/\/expertperspectives.com\/conference-reporter\/clarifying-the-association-between-obesity-and-endometrial-cancer\/.2025."},{"key":"3981_CR10","unstructured":"Report. KS. Study Finds Big Cause of DNA Changes That Lead to Cancer. March 2025.https:\/\/knowridge.com\/2025\/03\/study-finds-big-cause-of-dna-changes-that-lead-to-cancer\/.2025."},{"key":"3981_CR11","unstructured":"eBioMedicine. GWAS Meta-Analysis Identifies Five Susceptibility Loci for Endometrial Cancer. August 2025. https:\/\/medicalxpress.com\/news\/2025-08-genomic-factors-uterine-cancer.html.2025."},{"key":"3981_CR12","doi-asserted-by":"crossref","unstructured":"Santra D. Cell biology and cell behavior in cancer. Cancer Diagnostics and Therapeutics:Current Trends, Challenges, and Future Perspectives: Springer; 2022. p. 13\u201341.","DOI":"10.1007\/978-981-16-4752-9_2"},{"key":"3981_CR13","doi-asserted-by":"crossref","unstructured":"Motofei IG, editor Biology of cancer; from cellular and molecular mechanisms to developmental processes and adaptation. Seminars in Cancer Biology; 2022: Elsevier.","DOI":"10.1016\/j.semcancer.2021.10.003"},{"key":"3981_CR14","doi-asserted-by":"crossref","unstructured":"Mahapatra S, Mohanty S, Mishra R, Prasad P. An overview of cancer and the human microbiome. Progress in Molecular Biology and Translational Science. 2022;191(1):83\u2013139.","DOI":"10.1016\/bs.pmbts.2022.07.007"},{"key":"3981_CR15","doi-asserted-by":"publisher","DOI":"10.26689\/par.v8i5.7043","author":"M Abubakar","year":"2024","unstructured":"Abubakar M, Ayyoub R, Rehman B, Zubair M, Ahmed U. Advancing cancer stem cell-targeted therapeutic applications. Proc Anticancer Res. 2024. https:\/\/doi.org\/10.26689\/par.v8i5.7043.","journal-title":"Proc Anticancer Res"},{"key":"3981_CR16","doi-asserted-by":"publisher","unstructured":"Barati M, Akhondi M, Mousavi NS, Haghparast N, Ghodsi A, Baharvand H, et al. Pluripotent stem cells: cancer study, therapy, and vaccination. Stem Cell Rev Rep. 2021;18. https:\/\/doi.org\/10.1007\/s12015-021-10199-7.","DOI":"10.1007\/s12015-021-10199-7"},{"key":"3981_CR17","unstructured":"Ghosh S, Ts DP, Chourasia RK, Mahmood AAR. CANCER STEM CELLS: Cancer Stem Cells:Potential For Treatment. International Journal of Trends in OncoScience. 2023:1\u201312."},{"key":"3981_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/10732748241274196","volume":"31","author":"C Zhong","year":"2024","unstructured":"Zhong C, Wang G, Guo M, Zhu N, Chen X, Yan Y, et al. The role of tumor stem cells in colorectal cancer drug resistance. Cancer Control. 2024;31:10732748241274196.","journal-title":"Cancer Control"},{"key":"3981_CR19","doi-asserted-by":"crossref","unstructured":"Amiri-Farsani M, Taheri Z, Tirbakhsh Gouran S, Chabok O, Safarpour-Dehkordi M,Kazemi Roudsari M. Cancer stem cells: Recent trends in cancer therapy. Nucleosides,Nucleotides & Nucleic Acids. 2024:1\u201332.","DOI":"10.1080\/15257770.2024.2311789"},{"issue":"1","key":"3981_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02064-1","volume":"23","author":"X Chu","year":"2024","unstructured":"Chu X, Tian Y, Lv C. Decoding the spatiotemporal heterogeneity of tumor-associated macrophages. Mol Cancer. 2024;23(1):150.","journal-title":"Mol Cancer"},{"key":"3981_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.vesic.2024.100038","volume":"3","author":"S Banerjee","year":"2024","unstructured":"Banerjee S, Sharma V, Mukhopadhyay CD. Exploring emerging concepts of exosomes for the diagnosis, prognosis, and therapeutics of brain cancers. Extracellular Vesicle. 2024;3:100038.","journal-title":"Extracellular Vesicle"},{"issue":"1","key":"3981_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03558-0","volume":"24","author":"BA Mengistu","year":"2024","unstructured":"Mengistu BA, Tsegaw T, Demessie Y, Getnet K, Bitew AB, Kinde MZ, et al. Comprehensive review of drug resistance in mammalian cancer stem cells: implications for cancer therapy. Cancer Cell Int. 2024;24(1):406.","journal-title":"Cancer Cell Int"},{"key":"3981_CR23","doi-asserted-by":"crossref","unstructured":"Pastrello MT, Iza\u00edas EP, Barboza GS, da Silva PLF, Alves WC, Barboza KRG, et al.Stem cells: concepts, applications and ethical implications. Seven Editora. 2024.","DOI":"10.56238\/sevened2023.007-034"},{"key":"3981_CR24","unstructured":"Faisal S. Comparative analysis and machine learning predictions of cervical cancer incidence: A multi-national study: Brac University; 2023."},{"issue":"12","key":"3981_CR25","doi-asserted-by":"publisher","first-page":"8002","DOI":"10.1097\/JS9.0000000000002109","volume":"110","author":"BM Hussen","year":"2024","unstructured":"Hussen BM, Taheri M, Yashooa RK, Abdullah GH, Abdullah SR, Kheder RK, et al. Revolutionizing medicine: recent developments and future prospects in stem-cell therapy. Int J Surg. 2024;110(12):8002\u201324.","journal-title":"Int J Surg"},{"key":"3981_CR26","doi-asserted-by":"crossref","unstructured":"Zhang L, Yu H, Du W, Chen S, Zhao Y-g, Yao J, et al. The Historical Overview of Stem Cells. Stem Cells in Clinical Application and Productization: Bentham Science Publishers; 2024. p. 1\u201317.","DOI":"10.2174\/9789815196627124010004"},{"issue":"3","key":"3981_CR27","doi-asserted-by":"publisher","first-page":"551","DOI":"10.4103\/mgmj.mgmj_155_24","volume":"11","author":"P Acharya","year":"2024","unstructured":"Acharya P, Nyamagoud SB. Revolutionizing medicine practice using stem cells in healthcare. MGM J Med Sci. 2024;11(3):551\u20137.","journal-title":"MGM J Med Sci"},{"key":"3981_CR28","doi-asserted-by":"crossref","unstructured":"Ali MS. Cancer stem cells. Understanding Cancer: Elsevier; 2022. p. 187\u2013204.","DOI":"10.1016\/B978-0-323-99883-3.00005-6"},{"key":"3981_CR29","doi-asserted-by":"crossref","unstructured":"Kumarasamy VM, Lee CS, Mittan S. The Emergence of Cancer Stem Cells in Early Diagnosed Prostate Cancer. LWW; 2022.","DOI":"10.1097\/01.COT.0000899260.61858.b4"},{"issue":"5","key":"3981_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0635-5","volume":"9","author":"L Mele","year":"2018","unstructured":"Mele L, Paino F, Papaccio F, Regad T, Boocock D, Stiuso P, et al. A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo. Cell Death Dis. 2018;9(5):572.","journal-title":"Cell Death Dis"},{"issue":"8","key":"3981_CR31","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.neo.2019.06.005","volume":"21","author":"MRW Rashidi","year":"2019","unstructured":"Rashidi MRW, Mehta P, Bregenzer M, Raghavan S, Fleck EM, Horst EN, et al. Engineered 3d model of cancer stem cell enrichment and chemoresistance. Neoplasia. 2019;21(8):822\u201336.","journal-title":"Neoplasia"},{"issue":"7","key":"3981_CR32","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/carcin\/bgab042","volume":"42","author":"JE Trosko","year":"2021","unstructured":"Trosko JE. On the potential origin and characteristics of cancer stem cells. Carcinogenesis. 2021;42(7):905\u201312.","journal-title":"Carcinogenesis"},{"key":"3981_CR33","doi-asserted-by":"crossref","unstructured":"Chu B, Sun W, Wang Y, Zhang Y, Yuan Y, Yang L, et al. Synergistic Effects of Niraparib and Anlotinib on Suppressing the Growth of Ovarian Cancer and Stem-Like Cells by Inhibiting PI3K\/Akt Signalling. 2024.","DOI":"10.21203\/rs.3.rs-4779183\/v1"},{"issue":"4","key":"3981_CR34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s41048-018-0062-2","volume":"4","author":"P Zhu","year":"2018","unstructured":"Zhu P, Fan Z. Cancer stem cells and tumorigenesis. Biophys Rep. 2018;4(4):178\u201388.","journal-title":"Biophys Rep"},{"issue":"1","key":"3981_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01851-y","volume":"9","author":"X Chu","year":"2024","unstructured":"Chu X, Tian W, Ning J, Xiao G, Zhou Y, Wang Z, et al. Cancer stem cells: advances in knowledge and implications for cancer therapy. Signal Transduct Target Ther. 2024;9(1):170.","journal-title":"Signal Transduct Target Ther"},{"key":"3981_CR36","doi-asserted-by":"crossref","unstructured":"Afify SM, Seno M. Tumorigenic Potential of Cancer Stem Cells In Vivo. Methods in Cancer Stem Cell Biology: Springer; 2023. p. 203\u2009\u2013\u200914.","DOI":"10.1007\/978-981-99-1331-2_17"},{"issue":"5","key":"3981_CR37","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/neuonc\/noae011","volume":"26","author":"AR Sloan","year":"2024","unstructured":"Sloan AR, Silver DJ, Kint S, Gallo M, Lathia JD. Cancer stem cell hypothesis 2.0 in glioblastoma: where are we now and where are we going? Neuro-oncol. 2024;26(5):785\u201395.","journal-title":"Neuro-oncol"},{"issue":"1","key":"3981_CR38","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1158\/0008-5472.CAN-09-3663","volume":"70","author":"A Sottoriva","year":"2010","unstructured":"Sottoriva A, Verhoeff JJ, Borovski T, McWeeney SK, Naumov L, Medema JP, et al. Cancer stem cell tumor model reveals invasive morphology and increased phenotypical heterogeneity. Cancer Res. 2010;70(1):46\u201356.","journal-title":"Cancer Res"},{"key":"3981_CR39","doi-asserted-by":"crossref","unstructured":"Alnasser SM. Advances and Challenges in Cancer Stem Cells for Onco-Therapeutics.Stem Cells International. 2023;2023(1):8722803.","DOI":"10.1155\/2023\/8722803"},{"issue":"9","key":"3981_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07077-8","volume":"15","author":"B Son","year":"2024","unstructured":"Son B, Lee W, Kim H, Shin H, Park HH. Targeted therapy of cancer stem cells: inhibition of mTOR in pre-clinical and clinical research. Cell Death Dis. 2024;15(9):696.","journal-title":"Cell Death Dis"},{"key":"3981_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117486","volume":"180","author":"F Li","year":"2024","unstructured":"Li F, Li Z, Wei C, Xu L, Liang Y, Yan J, et al. Application of hydrogels for targeting cancer stem cells in cancer treatment. Biomed Pharmacother. 2024;180:117486.","journal-title":"Biomed Pharmacother"},{"key":"3981_CR42","doi-asserted-by":"crossref","unstructured":"Pang L, Wang B. Novel anti-cancer agents targeting tumour metastasis and stemness.Frontiers Media SA; 2024. p. 1504024.","DOI":"10.3389\/978-2-8325-5668-9"},{"key":"3981_CR43","unstructured":"Tadala S. Stem cell research and improving cancer treatments."},{"key":"3981_CR44","doi-asserted-by":"crossref","unstructured":"Alqarni A, Jasim SA, Altalbawy FM, Kaur H, Kaur I, Rodriguez-Benites C, et al.Challenges and opportunities for cancer stem cell\u2010targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell\u2010dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes. Journal of Biochemical and Molecular Toxicology. 2024;38(6):e23719.","DOI":"10.1002\/jbt.23719"},{"key":"3981_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104313","author":"S-Y Yi","year":"2024","unstructured":"Yi S-Y, Wei M-Z, Zhao L. Targeted immunotherapy to cancer stem cells: a novel strategy of anticancer immunotherapy. Critical Reviews in Oncology\/Hematology. 2024. https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104313.","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"7","key":"3981_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25074102","volume":"25","author":"MR MacLean","year":"2024","unstructured":"MacLean MR, Walker OL, Arun RP, Fernando W, Marcato P. Informed by cancer stem cells of solid tumors: advances in treatments targeting tumor-promoting factors and pathways. Int J Mol Sci. 2024;25(7):4102.","journal-title":"Int J Mol Sci"},{"key":"3981_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123033","author":"K Lavudi","year":"2024","unstructured":"Lavudi K, Nuguri SM, Pandey P, Kokkanti RR, Wang Q-E. ALDH and cancer stem cells: pathways, challenges, and future directions in targeted therapy. Life Sci. 2024. https:\/\/doi.org\/10.1016\/j.lfs.2024.123033.","journal-title":"Life Sci"},{"key":"3981_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1131874","volume":"14","author":"IM Khan","year":"2023","unstructured":"Khan IM, Khan SU, Sala HSS, Khan MU, Ud Din MA, Khan S, et al. TME-targeted approaches of brain metastases and its clinical therapeutic evidence. Front Immunol. 2023;14:1131874.","journal-title":"Front Immunol"},{"key":"3981_CR49","doi-asserted-by":"crossref","unstructured":"Masoudi M, Gopalan V. Roles of Cancer Stem Cells in Therapy Resistance and Disease Recurrence. Cancer Stem Cells: Basic Concept and Therapeutic Implications: Springer;2023. p. 149\u2009\u2013\u200965.","DOI":"10.1007\/978-981-99-3185-9_9"},{"key":"3981_CR50","doi-asserted-by":"publisher","first-page":"368","DOI":"10.54097\/m8qd7672","volume":"74","author":"B Lian","year":"2023","unstructured":"Lian B. Cancer stem cells: the elusive tumour population discussed. Highlights in Science, Engineering and Technology. 2023;74:368\u201377.","journal-title":"Highlights in Science, Engineering and Technology"},{"issue":"1","key":"3981_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-023-03406-4","volume":"14","author":"M Liu","year":"2023","unstructured":"Liu M, Zhou R, Zou W, Yang Z, Li Q, Chen Z, et al. Machine learning-identified stemness features and constructed stemness-related subtype with prognosis, chemotherapy, and immunotherapy responses for non-small cell lung cancer patients. Stem Cell Res Ther. 2023;14(1):238.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"3981_CR52","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4103\/jomfp.jomfp_248_24","volume":"28","author":"AS Manchanda","year":"2024","unstructured":"Manchanda AS, Rai HK, Kaur M, Arora P. Cancer stem cells targeted therapy: a changing concept in head and neck squamous cell carcinoma. J Oral Maxillofac Pathol. 2024;28(3):455\u201363.","journal-title":"J Oral Maxillofac Pathol"},{"issue":"4","key":"3981_CR53","doi-asserted-by":"publisher","first-page":"269","DOI":"10.52711\/2231-5691.2023.00049","volume":"13","author":"AA Masule","year":"2023","unstructured":"Masule AA, Murari VM. Utilization of stem cells for cancer treatment-a review. Asian J Pharm Res. 2023;13(4):269\u201376.","journal-title":"Asian J Pharm Res"},{"key":"3981_CR54","doi-asserted-by":"crossref","unstructured":"Maloui AB, El-Mansoury B, Hamdan YA, Oukhrib M, El Ghachi H, Tamegart L, et al.Stem Cells: The New Hope for Parkinson\u2019s Disease Treatment. Experimental and Clinical Evidence of the Neuropathology of Parkinson\u2019s Disease: IGI Global; 2023. p. 318\u2009\u2013\u200938.","DOI":"10.4018\/978-1-6684-5156-4.ch018"},{"issue":"1","key":"3981_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-023-03379-4","volume":"14","author":"M Rosner","year":"2023","unstructured":"Rosner M, Horer S, Feichtinger M, Hengstschl\u00e4ger M. Multipotent fetal stem cells in reproductive biology research. Stem Cell Res Ther. 2023;14(1):157.","journal-title":"Stem Cell Res Ther"},{"key":"3981_CR56","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ymeth.2015.09.016","volume":"99","author":"J Kobolak","year":"2016","unstructured":"Kobolak J, Dinnyes A, Memic A, Khademhosseini A, Mobasheri A. Mesenchymal stem cells: identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche. Methods. 2016;99:62\u20138.","journal-title":"Methods"},{"key":"3981_CR57","doi-asserted-by":"crossref","unstructured":"Anggraeni R, Ana ID. Stem Cells: Basic Understanding and Its Relevance to Regenerative Mechanism. 2024.","DOI":"10.1016\/B978-0-443-15717-2.00102-5"},{"issue":"3","key":"3981_CR58","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/0952813X.2012.694994","volume":"24","author":"MB Fagan","year":"2012","unstructured":"Fagan MB. Materia mathematica: Models in stem cell biology. J Exp Theor Artif Intell. 2012;24(3):315\u201327.","journal-title":"J Exp Theor Artif Intell"},{"issue":"2","key":"3981_CR59","doi-asserted-by":"publisher","first-page":"87","DOI":"10.17827\/aktd.1063647","volume":"31","author":"M Avc\u0131","year":"2022","unstructured":"Avc\u0131 M. K\u00f6k H\u00fccre; Tan\u0131m\u0131 ve Genel \u00d6zellikleri, Kullan\u0131m Alanlar\u0131, Tarihi, Y\u00fczey Belirte\u00e7leri. Ar\u015fiv Kaynak Tarama Dergisi. 2022;31(2):87\u201393.","journal-title":"Ar\u015fiv Kaynak Tarama Dergisi"},{"key":"3981_CR60","doi-asserted-by":"crossref","unstructured":"Zakrzewski W, Dobrzy\u0144ski M, Szymonowicz M, Rybak Z. Stem cells: past, present,and future. Stem cell research & therapy. 2019;10(1):1\u201322.","DOI":"10.1186\/s13287-019-1165-5"},{"issue":"09","key":"3981_CR61","doi-asserted-by":"publisher","first-page":"670","DOI":"10.53350\/pjmhs22169670","volume":"16","author":"A Shahid","year":"2022","unstructured":"Shahid A, Rehman HA, Hyder N, Ahmad S, Hassan MN. Molecular process of stem cells in modern biology. Pak J Med Health Sci. 2022;16(09):670.","journal-title":"Pak J Med Health Sci"},{"key":"3981_CR62","doi-asserted-by":"crossref","unstructured":"Pharoun J, Berro J, Sobh J, Abou-Younes M-M, Nasr L, Majed A, et al. Mesenchymal stem cells biological and biotechnological advances: Implications for clinical applications.European Journal of Pharmacology. 2024;977:176719.","DOI":"10.1016\/j.ejphar.2024.176719"},{"key":"3981_CR63","doi-asserted-by":"crossref","unstructured":"Kuntawala DH, McCann GJ. Basics of Stem Cells. Advances in Application of Stem Cells: From Bench to Clinics. 2021:1\u201323.","DOI":"10.1007\/978-3-030-78101-9_1"},{"key":"3981_CR64","doi-asserted-by":"crossref","unstructured":"B\u00e1rta T, Boha\u010diakov\u00e1 D, \u010caj\u00e1nek L. Self-renewal in induced pluripotent stem cells.Recent Advances in iPSC Technology: Elsevier; 2021. p. 179\u2013207.","DOI":"10.1016\/B978-0-12-822231-7.00007-2"},{"key":"3981_CR65","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.reth.2020.01.004","volume":"14","author":"EH Ntege","year":"2020","unstructured":"Ntege EH, Sunami H, Shimizu Y. Advances in regenerative therapy: a review of the literature and future directions. Regenerative therapy. 2020;14:136\u201353.","journal-title":"Regenerative therapy"},{"issue":"1","key":"3981_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-03968-x","volume":"15","author":"Z Wu","year":"2024","unstructured":"Wu Z, Su Y, Li J, Liu X, Liu Y, Zhao L, et al. Induced pluripotent stem cell-derived mesenchymal stem cells: whether they can become new stars of cell therapy. Stem Cell Res Ther. 2024;15(1):367.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3981_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04575-9","volume":"21","author":"Y-R Li","year":"2023","unstructured":"Li Y-R, Fang Y, Lyu Z, Zhu Y, Yang L. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies. J Transl Med. 2023;21(1):686.","journal-title":"J Transl Med"},{"issue":"2","key":"3981_CR68","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.tcb.2022.07.003","volume":"33","author":"MR Hicks","year":"2023","unstructured":"Hicks MR, Pyle AD. The emergence of the stem cell niche. Trends Cell Biol. 2023;33(2):112\u201323.","journal-title":"Trends Cell Biol"},{"key":"3981_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1220694","volume":"11","author":"X Luo","year":"2023","unstructured":"Luo X, Liu Z, Xu R. Adult tissue-specific stem cell interaction: novel technologies and research advances. Front Cell Dev Biol. 2023;11:1220694.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"3981_CR70","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/dgd.12816","volume":"64","author":"R Morita","year":"2022","unstructured":"Morita R, Fujiwara H. Tracing the developmental origin of tissue stem cells. Dev Growth Differ. 2022;64(9):566\u201376.","journal-title":"Dev Growth Differ"},{"key":"3981_CR71","doi-asserted-by":"crossref","unstructured":"Kitaeva K, Kiyasov A, Rizvanov A, Rutland C, Solovyeva V. Stem cells, fitness,and aging. Aging: Elsevier; 2023. p. 385\u2013405.","DOI":"10.1016\/B978-0-12-823761-8.00007-0"},{"issue":"12","key":"3981_CR72","doi-asserted-by":"publisher","first-page":"16636","DOI":"10.3390\/ijms131216636","volume":"13","author":"W Jiang","year":"2012","unstructured":"Jiang W, Peng J, Zhang Y, Cho WC, Jin K. The implications of cancer stem cells for cancer therapy. Int J Mol Sci. 2012;13(12):16636\u201357.","journal-title":"Int J Mol Sci"},{"issue":"1\u20133","key":"3981_CR73","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.mrrev.2010.01.007","volume":"704","author":"G Harfouche","year":"2010","unstructured":"Harfouche G, Martin MT. Response of normal stem cells to ionizing radiation: a balance between homeostasis and genomic stability. Mutation Research\/Reviews in Mutation Research. 2010;704(1\u20133):167\u201374.","journal-title":"Mutation Research\/Reviews in Mutation Research"},{"issue":"2","key":"3981_CR74","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1582-4934.2006.tb00400.x","volume":"10","author":"SV Perryman","year":"2006","unstructured":"Perryman SV, Sylvester KG. Repair and regeneration: opportunities for carcinogenesis from tissue stem cells. J Cell Mol Med. 2006;10(2):292\u2013308.","journal-title":"J Cell Mol Med"},{"key":"3981_CR75","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s11427-015-4865-9","volume":"58","author":"L Dong","year":"2015","unstructured":"Dong L, Hao H, Han W, Fu X. The role of the microenvironment on the fate of adult stem cells. Sci China Life Sci. 2015;58:639\u201348.","journal-title":"Sci China Life Sci"},{"issue":"6","key":"3981_CR76","doi-asserted-by":"publisher","first-page":"363","DOI":"10.5732\/cjc.30.0363","volume":"30","author":"PS Huang","year":"2011","unstructured":"Huang PS, Ho PT, Zhang K. A proposal: a comprehensive platform to characterize tumors in Chinese and improve success in cancer drug discovery and development. Chin J Cancer. 2011;30(6):363.","journal-title":"Chin J Cancer"},{"issue":"12","key":"3981_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122613","volume":"9","author":"C Lecerf","year":"2020","unstructured":"Lecerf C, Peperstraete E, Le Bourhis X, Adriaenssens E. Propagation and maintenance of cancer stem cells: a major influence of the long non-coding RNA H19. Cells. 2020;9(12):2613.","journal-title":"Cells"},{"key":"3981_CR78","doi-asserted-by":"crossref","unstructured":"Sharma M, Sobti RC, Rai S. Cancer stem cells. Handbook of oncobiology: from basic to clinical sciences: Springer; 2023. p. 1\u201317.","DOI":"10.1007\/978-981-99-2196-6_49-1"},{"key":"3981_CR79","unstructured":"Salehloo EB, Mozdoori N, Esmatabadi MJD, Hajigholami S, Bozorgmehr A. Cancer Stem Cell Biomarkers: Critical Roles, Challenges, Clinical Application, and Perspectives in Cancer Therapy. Basic & Clinical Cancer Research. 2022."},{"issue":"5","key":"3981_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12050715","volume":"12","author":"S Saito","year":"2022","unstructured":"Saito S, Ku C-C, Wuputra K, Pan J-B, Lin C-S, Lin Y-C, et al. Biomarkers of cancer stem cells for experimental research and clinical application. J Pers Med. 2022;12(5):715.","journal-title":"J Pers Med"},{"issue":"2","key":"3981_CR81","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1158\/0008-5472.CAN-22-2053","volume":"83","author":"L Lan","year":"2023","unstructured":"Lan L, Behrens A. Are there specific cancer stem cell markers? Cancer Res. 2023;83(2):170\u20132.","journal-title":"Cancer Res"},{"key":"3981_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01280","volume":"11","author":"L Walcher","year":"2020","unstructured":"Walcher L, Kistenmacher A-K, Suo H, Kitte R, Dluczek S, Strau\u00df A, et al. Cancer stem cells\u2014origins and biomarkers: perspectives for targeted personalized therapies. Front Immunol. 2020;11:1280.","journal-title":"Front Immunol"},{"key":"3981_CR83","doi-asserted-by":"crossref","unstructured":"Jemfer C, Blasco N, Durand S, Blin E, Mas R, Basly I, et al. Towards a standardised method for the characterisation and isolation of colorectal cancer stem cells by SdFFF and UHF-DEP: highlighted by transcriptomic analysis. bioRxiv. 2024:2024.11. 04.621916.","DOI":"10.1101\/2024.11.04.621916"},{"key":"3981_CR84","doi-asserted-by":"crossref","unstructured":"Jariyal H, Gupta C, Bhat VS, Wagh JR, Srivastava A. Advancements in cancer stem cell isolation and characterization. Stem cell reviews and reports. 2019;15:755\u2009\u2013\u200973.","DOI":"10.1007\/s12015-019-09912-4"},{"key":"3981_CR85","doi-asserted-by":"crossref","unstructured":"Thakur R, Kumari N, Mishra DP. Isolation and characterization of cancer stem cells.Protocol Handbook for Cancer Biology: Elsevier; 2021. p. 87\u2013105.","DOI":"10.1016\/B978-0-323-90006-5.00007-0"},{"issue":"2","key":"3981_CR86","doi-asserted-by":"publisher","first-page":"552","DOI":"10.7150\/ijbs.76187","volume":"19","author":"L Zhang","year":"2023","unstructured":"Zhang L, Chen W, Liu S, Chen C. Targeting breast cancer stem cells. Int J Biol Sci. 2023;19(2):552.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"3981_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9020178","volume":"9","author":"G Thakur","year":"2021","unstructured":"Thakur G, Kumar R, Kim S-B, Lee S-Y, Lee S-L, Rho G-J. Therapeutic status and available strategies in pancreatic ductal adenocarcinoma. Biomedicines. 2021;9(2):178.","journal-title":"Biomedicines"},{"key":"3981_CR88","doi-asserted-by":"crossref","unstructured":"Nalini N, Pratima BJ. Isolation and Characterization of Cancer Stem Cells (CSCs).Cancer Stem Cells: New Horizons in Cancer Therapies. 2020:51\u201367.","DOI":"10.1007\/978-981-15-5120-8_3"},{"key":"3981_CR89","doi-asserted-by":"crossref","unstructured":"Batlle E, Clevers H. Cancer stem cells revisited. Nature medicine. 2017;23(10):1124-34.","DOI":"10.1038\/nm.4409"},{"issue":"3","key":"3981_CR90","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","volume":"14","author":"A Kreso","year":"2014","unstructured":"Kreso A, Dick JE. Evolution of the cancer stem cell model. Cell Stem Cell. 2014;14(3):275\u201391.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"3981_CR91","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao M-J, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4):704\u201315.","journal-title":"Cell"},{"issue":"5","key":"3981_CR92","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871\u201390.","journal-title":"Cell"},{"key":"3981_CR93","doi-asserted-by":"crossref","unstructured":"Nieto MA, Huang RY-J, Jackson RA, Thiery JP. EMT: 2016. Cell. 2016;166(1):21\u201345.","DOI":"10.1016\/j.cell.2016.06.028"},{"key":"3981_CR94","doi-asserted-by":"crossref","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis.Nature medicine. 2013;19(11):1423-37.","DOI":"10.1038\/nm.3394"},{"key":"3981_CR95","doi-asserted-by":"crossref","unstructured":"Vazquez-Martin A, Van den Haute C, Cuf\u00ed S, Corominas-Faja B, Cuy\u00e0s E, Lopez-Bonet E, et al. Mitophagy-driven mitochondrial rejuvenation regulates stem cell fate. Aging(Albany NY). 2016;8(7):1330.","DOI":"10.18632\/aging.100976"},{"key":"3981_CR96","doi-asserted-by":"crossref","unstructured":"Easwaran H, Tsai H-C, Baylin SB. Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Molecular cell. 2014;54(5):716\u2009\u2013\u200927.","DOI":"10.1016\/j.molcel.2014.05.015"},{"issue":"7467","key":"3981_CR97","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature12624","volume":"501","author":"CE Meacham","year":"2013","unstructured":"Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity. Nature. 2013;501(7467):328\u201337.","journal-title":"Nature"},{"issue":"11","key":"3981_CR98","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-018-0056-x","volume":"18","author":"NK Lytle","year":"2018","unstructured":"Lytle NK, Barber AG, Reya T. Stem cell fate in cancer growth, progression and therapy resistance. Nat Rev Cancer. 2018;18(11):669\u201380.","journal-title":"Nat Rev Cancer"},{"key":"3981_CR99","doi-asserted-by":"crossref","unstructured":"Lobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Annu Rev Cell Dev Biol. 2007;23(1):675\u2009\u2013\u200999.","DOI":"10.1146\/annurev.cellbio.22.010305.104154"},{"issue":"6230","key":"3981_CR100","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015;348(6230):74\u201380.","journal-title":"Science"},{"key":"3981_CR101","doi-asserted-by":"crossref","unstructured":"Valent P, Bonnet D, De Maria R, Lapidot T, Copland M, Melo JV, et al. Cancer stem cell definitions and terminology: the devil is in the details. Nature Reviews Cancer. 2012;12(11):767\u2009\u2013\u200975.","DOI":"10.1038\/nrc3368"},{"issue":"2","key":"3981_CR102","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ccell.2014.11.017","volume":"27","author":"H Wang","year":"2015","unstructured":"Wang H, Yu C, Gao X, Welte T, Muscarella AM, Tian L, et al. The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells. Cancer Cell. 2015;27(2):193\u2013210.","journal-title":"Cancer Cell"},{"issue":"42","key":"3981_CR103","doi-asserted-by":"publisher","first-page":"44191","DOI":"10.18632\/oncotarget.6176","volume":"6","author":"T Wang","year":"2015","unstructured":"Wang T, Shigdar S, Gantier MP, Hou Y, Wang L, Li Y, et al. Cancer stem cell targeted therapy: progress amid controversies. Oncotarget. 2015;6(42):44191.","journal-title":"Oncotarget"},{"issue":"1","key":"3981_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-022-02760-z","volume":"13","author":"Y Hou","year":"2022","unstructured":"Hou Y, Ding W, Wu P, Liu C, Ding L, Liu J, et al. Adipose-derived stem cells alleviate liver injury induced by type 1 diabetes mellitus by inhibiting mitochondrial stress and attenuating inflammation. Stem Cell Res Ther. 2022;13(1):132.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"3981_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14040976","volume":"14","author":"B Aramini","year":"2022","unstructured":"Aramini B, Masciale V, Grisendi G, Bertolini F, Maur M, Guaitoli G, et al. Dissecting tumor growth: the role of cancer stem cells in drug resistance and recurrence. Cancers. 2022;14(4):976.","journal-title":"Cancers"},{"issue":"12","key":"3981_CR106","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/stcltm\/szad061","volume":"12","author":"GL Semenza","year":"2023","unstructured":"Semenza GL. Mechanisms of breast cancer stem cell specification and self-renewal mediated by hypoxia-inducible factor 1. Stem Cells Transl Med. 2023;12(12):783\u201390.","journal-title":"Stem Cells Transl Med"},{"issue":"3","key":"3981_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030376","volume":"13","author":"M Marzagalli","year":"2021","unstructured":"Marzagalli M, Fontana F, Raimondi M, Limonta P. Cancer stem cells\u2014key players in tumor relapse. Cancers. 2021;13(3):376.","journal-title":"Cancers"},{"key":"3981_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107985","volume":"231","author":"R Paul","year":"2022","unstructured":"Paul R, Dorsey JF, Fan Y. Cell plasticity, senescence, and quiescence in cancer stem cells: biological and therapeutic implications. Pharmacol Ther. 2022;231:107985.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"3981_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01877-w","volume":"22","author":"Z Zeng","year":"2023","unstructured":"Zeng Z, Fu M, Hu Y, Wei Y, Wei X, Luo M. Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer. Mol Cancer. 2023;22(1):172.","journal-title":"Mol Cancer"},{"key":"3981_CR110","doi-asserted-by":"crossref","unstructured":"Peri SS, Narayanaa Y K, Hubert TD, Rajaraman R, Arfuso F, Sundaram S, et al.Navigating Tumour Microenvironment and Wnt Signalling Crosstalk: Implications for Advanced Cancer Therapeutics. Cancers. 2023;15(24):5847.","DOI":"10.3390\/cancers15245847"},{"issue":"6","key":"3981_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061239","volume":"13","author":"L Jahangiri","year":"2021","unstructured":"Jahangiri L, Ishola T, Pucci P, Trigg RM, Pereira J, Williams JA, et al. The role of autophagy and lncRNAs in the maintenance of cancer stem cells. Cancers. 2021;13(6):1239.","journal-title":"Cancers"},{"issue":"1","key":"3981_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03894-1","volume":"21","author":"X Li","year":"2023","unstructured":"Li X, Li L, Wu J. The members of the miR-148\/152 family inhibit cancer stem cell-like properties in gastric cancer via negative regulation of ITGA5. J Transl Med. 2023;21(1):105.","journal-title":"J Transl Med"},{"key":"3981_CR113","doi-asserted-by":"crossref","unstructured":"Chakraborty S, Mukherjee S, Basak U, Pati S, Dutta A, Dutta S, et al. Immune evasion by cancer stem cells ensures tumor initiation and failure of immunotherapy.Exploration of Immunology. 2023;3(4):384\u2013405.","DOI":"10.37349\/ei.2023.00108"},{"key":"3981_CR114","doi-asserted-by":"crossref","unstructured":"Fernandes Q, Folorunsho OG. Circulating Cancer Stem Cells; Role in Cancer Prognosis Metastasis and Targeted Therapy. 2024.","DOI":"10.1016\/B978-0-443-15717-2.00097-4"},{"key":"3981_CR115","doi-asserted-by":"crossref","unstructured":"Aarthi V, Chattopadhyay I. Role of cancer stem cells in developing chemoresistance of solid tumor. Cancer Stem Cells and Signaling Pathways: Elsevier; 2024. p. 119\u2009\u2013\u200933.","DOI":"10.1016\/B978-0-443-13212-4.00020-9"},{"issue":"6","key":"3981_CR116","doi-asserted-by":"publisher","first-page":"750","DOI":"10.2174\/1574888X17666221003125208","volume":"18","author":"T Patil","year":"2023","unstructured":"Patil T, Rohiwal SS, Tiwari AP. Stem cells: therapeutic implications in chemotherapy and radiotherapy resistance in cancer therapy. Curr Stem Cell Res Ther. 2023;18(6):750\u201365.","journal-title":"Curr Stem Cell Res Ther"},{"issue":"13","key":"3981_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133399","volume":"15","author":"J Krishnaraj","year":"2023","unstructured":"Krishnaraj J, Yamamoto T, Ohki R. P53-dependent cytoprotective mechanisms behind resistance to chemo-radiotherapeutic agents used in cancer treatment. Cancers. 2023;15(13):3399.","journal-title":"Cancers"},{"issue":"22","key":"3981_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212402","volume":"25","author":"M Roszkowska","year":"2024","unstructured":"Roszkowska M. Multilevel mechanisms of cancer drug resistance. Int J Mol Sci. 2024;25(22):12402.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"3981_CR119","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.710","volume":"5","author":"TC Dakal","year":"2024","unstructured":"Dakal TC, Bhushan R, Xu C, Gadi BR, Cameotra SS, Yadav V, et al. Intricate relationship between cancer stemness, metastasis, and drug resistance. MedComm. 2024;5(10):e710.","journal-title":"MedComm"},{"key":"3981_CR120","doi-asserted-by":"crossref","unstructured":"Zahra MH, Nawara HM, Hassan G, Afify SM, Seno A, Seno M. Cancer stem cells contribute to drug resistance in multiple different ways. Cancer Stem Cell Markers and Related Network Pathways: Springer; 2023. p. 125\u2009\u2013\u200939.","DOI":"10.1007\/978-3-031-12974-2_6"},{"issue":"6","key":"3981_CR121","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061897","volume":"15","author":"MS Gillespie","year":"2023","unstructured":"Gillespie MS, Ward CM, Davies CC. DNA repair and therapeutic strategies in cancer stem cells. Cancers. 2023;15(6):1897.","journal-title":"Cancers"},{"key":"3981_CR122","doi-asserted-by":"crossref","unstructured":"Wang Y, Wang C, He S, Bai L, Kong F, Wang S, et al. Induction chemotherapy regimen of docetaxel plus cisplatin versus docetaxel, cisplatin plus fluorouracil followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma:Preliminary results of an open-label, noninferiority, multicentre, randomised, controlled phase 3 trial. EClinicalMedicine. 2022;53.","DOI":"10.1016\/j.eclinm.2022.101625"},{"key":"3981_CR123","doi-asserted-by":"crossref","unstructured":"Fatima K, Jan S, Malik F, Khan SU. Role of Cancer Stem Cells in Drug Resistance.Drug Resistance in Cancer: Mechanisms and Strategies: Springer; 2024. p. 77\u2013120.","DOI":"10.1007\/978-981-97-1666-1_3"},{"key":"3981_CR124","doi-asserted-by":"crossref","unstructured":"Jin ML, Jeong KW. Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective. Experimental & Molecular Medicine. 2023;55(7):1333-47.","DOI":"10.1038\/s12276-023-01014-z"},{"issue":"1","key":"3981_CR125","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-021-01107-4","volume":"13","author":"S Keyvani-Ghamsari","year":"2021","unstructured":"Keyvani-Ghamsari S, Khorsandi K, Rasul A, Zaman MK. Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance. Clin Epigenetics. 2021;13(1):120.","journal-title":"Clin Epigenetics"},{"key":"3981_CR126","doi-asserted-by":"crossref","unstructured":"Radisky DC, LaBarge MA. Epithelial-mesenchymal transition and the stem cell phenotype.Cell stem cell. 2008;2(6):511-2.","DOI":"10.1016\/j.stem.2008.05.007"},{"key":"3981_CR127","doi-asserted-by":"crossref","unstructured":"Paciucci R, Carnero A, LLeonart ME. Reciprocal crosstalk between the tumor microenvironment and cancer stem cells. Frontiers Media SA; 2024. p. 1505225.","DOI":"10.3389\/fimmu.2024.1505225"},{"issue":"11","key":"3981_CR128","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1080\/03007995.2024.2407963","volume":"40","author":"LS Ali","year":"2024","unstructured":"Ali LS, Attia YA, Mourad S, Halawa EM, Abd Elghaffar NH, Shokry S, et al. The missing link between cancer stem cells and immunotherapy. Curr Med Res Opin. 2024;40(11):1963\u201384.","journal-title":"Curr Med Res Opin"},{"key":"3981_CR129","doi-asserted-by":"crossref","unstructured":"Zhong H, Zhou S, Yin S, Qiu Y, Liu B, Yu H. Tumor microenvironment as niche constructed by cancer stem cells: Breaking the ecosystem to combat cancer. Journal of Advanced Research. 2024.","DOI":"10.1016\/j.jare.2024.06.014"},{"issue":"21","key":"3981_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215318","volume":"13","author":"AJ Petty","year":"2021","unstructured":"Petty AJ, Owen DH, Yang Y, Huang X. Targeting tumor-associated macrophages in cancer immunotherapy. Cancers (Basel). 2021;13(21):5318.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"3981_CR131","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.it.2019.02.003","volume":"40","author":"P Pathria","year":"2019","unstructured":"Pathria P, Louis TL, Varner JA. Targeting tumor-associated macrophages in cancer. Trends Immunol. 2019;40(4):310\u201327.","journal-title":"Trends Immunol"},{"issue":"4","key":"3981_CR132","doi-asserted-by":"publisher","DOI":"10.1002\/mog2.62","volume":"2","author":"J Talukdar","year":"2023","unstructured":"Talukdar J, Srivastava TP, Sahoo OS, Karmakar A, Rai AK, Sarma A, et al. Cancer stem cells: signaling pathways and therapeutic targeting. MedComm\u2013Oncology. 2023;2(4):e62.","journal-title":"MedComm\u2013Oncology"},{"key":"3981_CR133","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1221175","volume":"11","author":"A Ordaz-Ramos","year":"2023","unstructured":"Ordaz-Ramos A, Tellez-Jimenez O, Vazquez-Santillan K. Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications. Front Cell Dev Biol. 2023;11:1221175.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"3981_CR134","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.176","volume":"3","author":"W Manni","year":"2022","unstructured":"Manni W, Min W. Signaling pathways in the regulation of cancer stem cells and associated targeted therapy. MedComm. 2022;3(4):e176.","journal-title":"MedComm"},{"key":"3981_CR135","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1125174","volume":"11","author":"MC Borlongan","year":"2023","unstructured":"Borlongan MC, Wang H. Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics. Front Cell Dev Biol. 2023;11:1125174.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"3981_CR136","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03130-2","volume":"23","author":"Q Liu","year":"2023","unstructured":"Liu Q, Guo Z, Li G, Zhang Y, Liu X, Li B, et al. Cancer stem cells and their niche in cancer progression and therapy. Cancer Cell Int. 2023;23(1):305.","journal-title":"Cancer Cell Int"},{"key":"3981_CR137","doi-asserted-by":"crossref","unstructured":"Agarwal S, Saha L, Sohani A, Karri U, Gor R, Ramalingam S. The importance of niche in therapeutic strategies targeting normal and cancer stem cells. Cancer Stem Cells and Signaling Pathways: Elsevier; 2024. p. 15\u201333.","DOI":"10.1016\/B978-0-443-13212-4.00031-3"},{"issue":"1","key":"3981_CR138","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02106-8","volume":"23","author":"Z Lin","year":"2024","unstructured":"Lin Z, Li G, Jiang K, Li Z, Liu T. Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular vesicles: biological mechanisms to clinical significance and implications. Mol Cancer. 2024;23(1):191.","journal-title":"Mol Cancer"},{"key":"3981_CR139","doi-asserted-by":"crossref","unstructured":"Mekapogu AR, Su\u00e1rez CA, Wang JY. Exploring cancer stem cells signaling pathways.Frontiers Media SA; 2023. p. 1274509.","DOI":"10.3389\/fonc.2023.1274509"},{"key":"3981_CR140","doi-asserted-by":"crossref","unstructured":"Thomas A, Pathak N, Moses L, Munirathinam G. Components of cancer stem cells microenvironment: influence on the tumorigenic property and stemness in cancer stem cells. Cancer Stem Cells and Signaling Pathways: Elsevier; 2024. p. 549\u2009\u2013\u200979.","DOI":"10.1016\/B978-0-443-13212-4.00002-7"},{"issue":"21","key":"3981_CR141","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215345","volume":"14","author":"Y Xie","year":"2022","unstructured":"Xie Y, Ma S, Tong M. Metabolic plasticity of cancer stem cells in response to microenvironmental cues. Cancers (Basel). 2022;14(21):5345.","journal-title":"Cancers (Basel)"},{"issue":"1\u20132","key":"3981_CR142","first-page":"64","volume":"39","author":"H Sarkar","year":"2025","unstructured":"Sarkar H, Lee E, Lopez-Darwin SL, Kang Y. Deciphering normal and cancer stem cell niches by spatial transcriptomics: opportunities and challenges. Genes Dev. 2025;39(1\u20132):64\u201385.","journal-title":"Genes Dev"},{"key":"3981_CR143","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2022.1095842","volume":"3","author":"PJ Polverini","year":"2023","unstructured":"Polverini PJ, N\u00f6r F, N\u00f6r JE. Crosstalk between cancer stem cells and the tumor microenvironment drives progression of premalignant oral epithelium. Front Oral Health. 2023;3:1095842.","journal-title":"Front Oral Health"},{"key":"3981_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1404628","author":"OA Bamodu","year":"2024","unstructured":"Bamodu OA, Chung C-C, Pisanic TR, Wu AT. The intricate interplay between cancer stem cells and cell-of-origin of cancer: implications for therapeutic strategies. Front Oncol. 2024. https:\/\/doi.org\/10.3389\/fonc.2024.1404628.","journal-title":"Front Oncol"},{"key":"3981_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.849905","volume":"10","author":"PN Avalos","year":"2022","unstructured":"Avalos PN, Forsthoefel DJ. An emerging frontier in intercellular communication: extracellular vesicles in regeneration. Front Cell Dev Biol. 2022;10:849905.","journal-title":"Front Cell Dev Biol"},{"issue":"6189","key":"3981_CR146","doi-asserted-by":"publisher","DOI":"10.1126\/science.1242281","volume":"344","author":"C Blanpain","year":"2014","unstructured":"Blanpain C, Fuchs E. Plasticity of epithelial stem cells in tissue regeneration. Science. 2014;344(6189):1242281.","journal-title":"Science"},{"key":"3981_CR147","doi-asserted-by":"crossref","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. nature. 2001;414(6859):105\u2009\u2013\u200911.","DOI":"10.1038\/35102167"},{"issue":"3","key":"3981_CR148","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nrm2636","volume":"10","author":"C Blanpain","year":"2009","unstructured":"Blanpain C, Fuchs E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol. 2009;10(3):207\u201317.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3981_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/197452a0","author":"AJ Becker","year":"1963","unstructured":"Becker AJ, McCulloch EA, Till JE. Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature. 1963. https:\/\/doi.org\/10.1038\/197452a0.","journal-title":"Nature"},{"issue":"7","key":"3981_CR150","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3(7):730\u20137.","journal-title":"Nat Med"},{"issue":"8","key":"3981_CR151","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/1074-7613(94)90037-X","volume":"1","author":"SJ Morrison","year":"1994","unstructured":"Morrison SJ, Weissman IL. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity. 1994;1(8):661\u201373.","journal-title":"Immunity"},{"issue":"13","key":"3981_CR152","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1182\/blood-2008-08-077941","volume":"112","author":"JE Dick","year":"2008","unstructured":"Dick JE. Stem cell concepts renew cancer research. Blood. 2008;112(13):4793\u2013807.","journal-title":"Blood"},{"key":"3981_CR153","unstructured":"Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Cell-cell adhesion.Molecular Biology of the Cell 4th edition: Garland Science; 2002."},{"issue":"5","key":"3981_CR154","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. cell. 2011;144(5):646\u201374.","journal-title":"cell"},{"issue":"2","key":"3981_CR155","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1159\/000430138","volume":"36","author":"V Pozzi","year":"2015","unstructured":"Pozzi V, Sartini D, Rocchetti R, Santarelli A, Rubini C, Morganti S, et al. Identification and characterization of cancer stem cells from head and neck squamous cell carcinoma cell lines. Cell Physiol Biochem. 2015;36(2):784\u201398.","journal-title":"Cell Physiol Biochem"},{"issue":"12","key":"3981_CR156","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMra061808","volume":"355","author":"CT Jordan","year":"2006","unstructured":"Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med. 2006;355(12):1253\u201361.","journal-title":"N Engl J Med"},{"issue":"19","key":"3981_CR157","doi-asserted-by":"publisher","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","volume":"66","author":"MF Clarke","year":"2006","unstructured":"Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, et al. Cancer stem cells\u2014perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 2006;66(19):9339\u201344.","journal-title":"Cancer Res"},{"issue":"5","key":"3981_CR158","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.cell.2009.08.017","volume":"138","author":"M Shackleton","year":"2009","unstructured":"Shackleton M, Quintana E, Fearon ER, Morrison SJ. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell. 2009;138(5):822\u20139.","journal-title":"Cell"},{"key":"3981_CR159","doi-asserted-by":"crossref","unstructured":"Sell S. Stem cells and cancer: an introduction. Stem Cells and Cancer. 2009:1\u201331.","DOI":"10.1007\/978-0-387-89611-3_1"},{"issue":"6","key":"3981_CR160","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.stem.2012.05.007","volume":"10","author":"JE Visvader","year":"2012","unstructured":"Visvader JE, Lindeman GJ. Cancer stem cells: current status and evolving complexities. Cell Stem Cell. 2012;10(6):717\u201328.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"3981_CR161","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-020-02018-6","volume":"11","author":"F Rossi","year":"2020","unstructured":"Rossi F, Noren H, Jove R, Beljanski V, Grinnemo K-H. Differences and similarities between cancer and somatic stem cells: therapeutic implications. Stem Cell Res Ther. 2020;11(1):489.","journal-title":"Stem Cell Res Ther"},{"key":"3981_CR162","doi-asserted-by":"crossref","unstructured":"Wang J, Qu J, Hou Q, Huo X, Zhao X, Chang L, et al. Strategies for the Isolation and Identification of Gastric Cancer Stem Cells. Stem Cells International. 2024;2024(1):5553852.","DOI":"10.1155\/2024\/5553852"},{"key":"3981_CR163","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1464698","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang Y, Ma L, He J, Gu H, Zhu H. Identification of cancer stem cell-related genes through single cells and machine learning for predicting prostate cancer prognosis and immunotherapy. Front Immunol. 2024;15:1464698.","journal-title":"Front Immunol"},{"key":"3981_CR164","doi-asserted-by":"crossref","unstructured":"Borah A, Kumar DS. Targeting the hedgehog and notch signaling pathways in cancer stem cells. Oncogenomics: Elsevier; 2019. p. 103\u2009\u2013\u200920.","DOI":"10.1016\/B978-0-12-811785-9.00008-9"},{"issue":"3","key":"3981_CR165","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/fcp.12982","volume":"38","author":"M Radak","year":"2024","unstructured":"Radak M, Fallahi H. Cell\u2013cell communication in stem cells and cancer: alone but in touch. Fundam Clin Pharmacol. 2024;38(3):479\u201388.","journal-title":"Fundam Clin Pharmacol"},{"key":"3981_CR166","doi-asserted-by":"crossref","unstructured":"Pan Y, Yuan C, Zeng C, Sun C, Xia L, Wang G, et al. Cancer stem cells and niches:challenges in immunotherapy resistance. Molecular Cancer. 2025;24(1):1\u201322.","DOI":"10.1186\/s12943-025-02265-2"},{"issue":"1","key":"3981_CR167","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02360-2","volume":"10","author":"H Lee","year":"2025","unstructured":"Lee H, Kim B, Park J, Park S, Yoo G, Yum S, et al. Cancer stem cells: landscape,challenges and emerging therapeutic innovations. Signal Transduct Target Ther. 2025;10(1):248.","journal-title":"Signal Transduct Target Ther"},{"key":"3981_CR168","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1274509","volume":"13","author":"AR Mekapogu","year":"2023","unstructured":"Mekapogu AR, Su\u00e1rez CA, Wang JY. Exploring cancer stem cells signaling pathways. Front Oncol. 2023;13:1274509.","journal-title":"Front Oncol"},{"issue":"13","key":"3981_CR169","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17132100","volume":"17","author":"SV Mathan","year":"2025","unstructured":"Mathan SV, Singh RP. Cancer stem cells connecting to immunotherapy: key insights,challenges, and potential treatment opportunities. Cancers. 2025;17(13):2100.","journal-title":"Cancers"},{"issue":"2","key":"3981_CR170","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.yexmp.2015.02.002","volume":"98","author":"F Islam","year":"2015","unstructured":"Islam F, Qiao B, Smith RA, Gopalan V, Lam AK-Y. Cancer stem cell: fundamental experimental pathological concepts and updates. Exp Mol Pathol. 2015;98(2):184\u201391.","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"3981_CR171","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-04061-z","volume":"15","author":"Q Li","year":"2024","unstructured":"Li Q, He G, Yu Y, Li X, Peng X, Yang L. Exosome crosstalk between cancer stem cells and tumor microenvironment: cancer progression and therapeutic strategies. Stem Cell Res Ther. 2024;15(1):449.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"3981_CR172","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12307-019-00233-1","volume":"12","author":"S Ravindran","year":"2019","unstructured":"Ravindran S, Rasool S, Maccalli C. The cross talk between cancer stem cells\/cancer initiating cells and tumor microenvironment: the missing piece of the puzzle for the efficient targeting of these cells with immunotherapy. Cancer Microenviron. 2019;12(2):133\u201348.","journal-title":"Cancer Microenviron"},{"key":"3981_CR173","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-018-0426-4","volume":"25","author":"AZ Ayob","year":"2018","unstructured":"Ayob AZ, Ramasamy TS. Cancer stem cells as key drivers of tumour progression. J Biomed Sci. 2018;25:1\u201318.","journal-title":"J Biomed Sci"},{"issue":"28","key":"3981_CR174","doi-asserted-by":"publisher","first-page":"16208","DOI":"10.1039\/C9RA02472G","volume":"9","author":"Y Wang","year":"2019","unstructured":"Wang Y, Zhao B, Wang L, Bu W, Liu S, Sun B. Nanoparticles based on retinoic acid caped with ferrocenium: a novel synthesized targetable nanoparticle both with anti-cancer effect and drug loading capacity. RSC Adv. 2019;9(28):16208\u201314.","journal-title":"RSC Adv"},{"key":"3981_CR175","doi-asserted-by":"crossref","unstructured":"Phi LTH, Sari IN, Yang Y-G, Lee S-H, Jun N, Kim KS, et al. Cancer stem cells(CSCs) in drug resistance and their therapeutic implications in cancer treatment.Stem cells international. 2018;2018(1):5416923.","DOI":"10.1155\/2018\/5416923"},{"key":"3981_CR176","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ymeth.2015.04.022","volume":"82","author":"S McClellan","year":"2015","unstructured":"McClellan S, Slamecka J, Howze P, Thompson L, Finan M, Rocconi R, et al. mRNA detection in living cells: a next generation cancer stem cell identification technique. Methods. 2015;82:47\u201354.","journal-title":"Methods"},{"issue":"2","key":"3981_CR177","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020346","volume":"9","author":"F Triana-Mart\u00ednez","year":"2020","unstructured":"Triana-Mart\u00ednez F, Loza M, Dom\u00ednguez E. Beyond tumor suppression: senescence in cancer stemness and tumor dormancy. Cells. 2020;9(2):346.","journal-title":"Cells"},{"issue":"8","key":"3981_CR178","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/nm.3915","volume":"21","author":"AA Alizadeh","year":"2015","unstructured":"Alizadeh AA, Aranda V, Bardelli A, Blanpain C, Bock C, Borowski C, et al. Toward understanding and exploiting tumor heterogeneity. Nat Med. 2015;21(8):846\u201353.","journal-title":"Nat Med"},{"issue":"7","key":"3981_CR179","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nrclinonc.2015.73","volume":"12","author":"D Zardavas","year":"2015","unstructured":"Zardavas D, Irrthum A, Swanton C, Piccart M. Clinical management of breast cancer heterogeneity. Nat Rev Clin Oncol. 2015;12(7):381\u201394.","journal-title":"Nat Rev Clin Oncol"},{"issue":"23","key":"3981_CR180","doi-asserted-by":"publisher","first-page":"23262","DOI":"10.1021\/acsnano.3c07828","volume":"17","author":"W-D Wang","year":"2023","unstructured":"Wang W-D, Guo Y-Y, Yang Z-L, Su G-L, Sun Z-J. Sniping cancer stem cells with nanomaterials. ACS Nano. 2023;17(23):23262\u201398.","journal-title":"ACS Nano"},{"issue":"5","key":"3981_CR181","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541\u201350.","journal-title":"Nat Med"},{"issue":"2","key":"3981_CR182","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA. New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20(2):69\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3981_CR183","doi-asserted-by":"crossref","unstructured":"Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate lymphoid cells: 10 years on. Cell. 2018;174(5):1054-66.","DOI":"10.1016\/j.cell.2018.07.017"},{"issue":"7693","key":"3981_CR184","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138.","journal-title":"Nature"},{"key":"3981_CR185","doi-asserted-by":"crossref","unstructured":"Terry S, Savagner P, Ortiz-Cuaran S, Mahjoubi L, Saintigny P, Thiery JP, et al.New insights into the role of EMT in tumor immune escape. Molecular oncology. 2017;11(7):824\u2009\u2013\u200946.","DOI":"10.1002\/1878-0261.12093"},{"issue":"6","key":"3981_CR186","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.tips.2015.03.003","volume":"36","author":"G Peng","year":"2015","unstructured":"Peng G, Liu Y. Hypoxia-inducible factors in cancer stem cells and inflammation. Trends Pharmacol Sci. 2015;36(6):374\u201383.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"3981_CR187","doi-asserted-by":"publisher","first-page":"18","DOI":"10.9734\/jcti\/2024\/v14i1247","volume":"14","author":"JW Sentoso","year":"2024","unstructured":"Sentoso JW, Putra A, Alif I. Targeting unique features of quiescent cancer stem cells to overcome resistance and recurrence in cancer therapy: a review. Journal of Cancer and Tumor International. 2024;14(1):18\u201331.","journal-title":"Journal of Cancer and Tumor International"},{"key":"3981_CR188","doi-asserted-by":"publisher","DOI":"10.1007\/s11748-024-02086-y","author":"N Oka","year":"2024","unstructured":"Oka N, Hishida T, Kaseda K, Suzuki Y, Okubo Y, Masai K, et al. Survival impact of pathologic features after salvage lung resection following definitive chemoradiotherapy or systemic therapy for initially unresectable lung cancer. Gen Thorac Cardiovasc Surg. 2024. https:\/\/doi.org\/10.1007\/s11748-024-02086-y.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"3981_CR189","doi-asserted-by":"crossref","unstructured":"Mizoo T, Oka T, Sugahara O, Minato T, Higa T, Nakayama KI. GPLD1\u2009+\u2009cancer stem cells contribute to chemotherapy resistance and tumor relapse in intestinal cancer.The Journal of Biochemistry. 2025:mvae082.","DOI":"10.1093\/jb\/mvae082"},{"key":"3981_CR190","doi-asserted-by":"crossref","unstructured":"Herrmann IK, R\u00f6sslein M. Personalized medicine: the enabling role of nanotechnology.Taylor & Francis; 2016. p. 1\u20133.","DOI":"10.2217\/nnm.15.152"},{"issue":"1","key":"3981_CR191","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01563-4","volume":"17","author":"P Song","year":"2024","unstructured":"Song P, Gao Z, Bao Y, Chen L, Huang Y, Liu Y, et al. Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy. Journal of Hematology& Oncology. 2024;17(1):46.","journal-title":"Journal of Hematology& Oncology"},{"key":"3981_CR192","doi-asserted-by":"crossref","unstructured":"Krzyszczyk P, Acevedo A, Davidoff EJ, Timmins LM, Marrero-Berrios I, Patel M,et al. The growing role of precision and personalized medicine for cancer treatment.Technology. 2018;6(03n04):79\u2013100.","DOI":"10.1142\/S2339547818300020"},{"issue":"1","key":"3981_CR193","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/annurev-genom-082410-101446","volume":"12","author":"IS Chan","year":"2011","unstructured":"Chan IS, Ginsburg GS. Personalized medicine: progress and promise. Annu Rev Genomics Hum Genet. 2011;12(1):217\u201344.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"3981_CR194","doi-asserted-by":"crossref","unstructured":"Luo N, Giurisato E, Morelli MB, Wu J, Sun S, Wang Y, et al. frontiers Frontiers in Molecular Biosciences ORIGINAL RESEARCH published: 10 May 2022. Volume II: Tumor Microenvironment in Cancer Hallmarks and Therapeutics. 2023:76.","DOI":"10.3389\/fmolb.2023.1182083"},{"key":"3981_CR195","unstructured":"Silva LC, Borgato GB, Wagner VP, Martins MD, Lopes MA, Santos-Silva AR, et al.Repurposing NF\u03baB and HDAC inhibitors to individually target cancer stem cells and non-cancer stem cells from mucoepidermoid carcinomas. American journal of cancer research. 2023;13(4):1547."},{"issue":"9","key":"3981_CR196","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04116-6","volume":"12","author":"K Chen","year":"2021","unstructured":"Chen K, Zhang C, Ling S, Wei R, Wang J, Xu X. The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance. Cell Death Dis. 2021;12(9):835.","journal-title":"Cell Death Dis"},{"key":"3981_CR197","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01010","volume":"10","author":"UP Yadav","year":"2020","unstructured":"Yadav UP, Singh T, Kumar P, Sharma P, Kaur H, Sharma S, et al. Metabolic adaptations in cancer stem cells. Front Oncol. 2020;10:1010.","journal-title":"Front Oncol"},{"key":"3981_CR198","doi-asserted-by":"crossref","unstructured":"Halbrook CJ, Lyssiotis CA, di Magliano MP, Maitra A. Pancreatic cancer: Advances and challenges. Cell. 2023;186(8):1729-54.","DOI":"10.1016\/j.cell.2023.02.014"},{"key":"3981_CR199","doi-asserted-by":"publisher","unstructured":"Nguyen CB, Tsung I, Lee JK, Pasquina LW, Kasputis A, Lovett JL, et al. Prognostic value of baseline circulating tumor DNA (ctDNA) tumor fraction (TF) in metastatic hormone-sensitive prostate cancer (mHSPC). J Clin Oncol. 2024. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.5085.","DOI":"10.1200\/JCO.2024.42.16_suppl.5085"},{"issue":"1","key":"3981_CR200","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.stem.2018.11.017","volume":"24","author":"C Saygin","year":"2019","unstructured":"Saygin C, Matei D, Majeti R, Reizes O, Lathia JD. Targeting cancer stemness in the clinic: from hype to hope. Cell Stem Cell. 2019;24(1):25\u201340.","journal-title":"Cell Stem Cell"},{"issue":"11","key":"3981_CR201","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1080\/03007995.2024.2416985","volume":"40","author":"NM Hamdy","year":"2024","unstructured":"Hamdy NM, Basalious EB, El-Sisi MG, Nasr M, Kabel AM, Nossier ES, et al. Advancements in current one-size-fits-all therapies compared to future treatment innovations for better improved chemotherapeutic outcomes: a step-toward personalized medicine. Curr Med Res Opin. 2024;40(11):1943\u201361.","journal-title":"Curr Med Res Opin"},{"key":"3981_CR202","doi-asserted-by":"crossref","unstructured":"Giron-Michel J, Padelli M, Oberlin E, Guenou H, Duclos-Vall\u00e9e J-C. State-of-the-Art Liver Cancer Organoids: Modeling Cancer Stem Cell Heterogeneity for Personalized Treatment.BioDrugs. 2025:1\u201324.","DOI":"10.1007\/s40259-024-00702-0"},{"issue":"3","key":"3981_CR203","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17030382","volume":"17","author":"M El-Tanani","year":"2025","unstructured":"El-Tanani M, Rabbani SA, Satyam SM, Rangraze IR, Wali AF, El-Tanani Y, et al. Deciphering the role of cancer stem cells: drivers of tumor evolution, therapeutic resistance, and precision medicine strategies. Cancers. 2025;17(3):382.","journal-title":"Cancers"},{"issue":"4","key":"3981_CR204","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.4055","volume":"42","author":"A Soroush","year":"2024","unstructured":"Soroush A, Shahhosseini R, Ghavamikia N, Hjazi A, Roudaki S, KhalatbariLimaki M, et al. Improvement of current immunotherapies with engineered oncolytic viruses that target cancer stem cells. Cell Biochem Funct. 2024;42(4):e4055.","journal-title":"Cell Biochem Funct"},{"key":"3981_CR205","doi-asserted-by":"crossref","unstructured":"Kanwar JR, Samarasinghe RM, Kamalapuram SK, Kanwar RK. Multimodal nanomedicine strategies for targeting cancer cells as well as cancer stem cell signalling mechanisms.Mini Reviews in Medicinal Chemistry. 2017;17(18):1688-95.","DOI":"10.2174\/1389557516666160219121634"},{"key":"3981_CR206","doi-asserted-by":"crossref","unstructured":"Basak O, Beumer J, Wiebrands K, Seno H, van Oudenaarden A, Clevers H. Induced quiescence of Lgr5\u2009+\u2009stem cells in intestinal organoids enables differentiation of hormone-producing enteroendocrine cells. Cell stem cell. 2017;20(2):177\u2009\u2013\u200990. e4.","DOI":"10.1016\/j.stem.2016.11.001"},{"issue":"1","key":"3981_CR207","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-pathol-012615-044438","volume":"11","author":"D Nassar","year":"2016","unstructured":"Nassar D, Blanpain C. Cancer stem cells: basic concepts and therapeutic implications. Annu Rev Pathol Mech Dis. 2016;11(1):47\u201376.","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"10","key":"3981_CR208","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue T, Weinberg RA. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol. 2017;14(10):611\u201329.","journal-title":"Nat Rev Clin Oncol"},{"key":"3981_CR209","doi-asserted-by":"crossref","unstructured":"Capp J-P. Cancer stem cells: from historical roots to a new perspective. Journal of oncology. 2019;2019(1):5189232.","DOI":"10.1155\/2019\/5189232"},{"issue":"5","key":"3981_CR210","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050616","volume":"11","author":"C Peitzsch","year":"2019","unstructured":"Peitzsch C, Nathansen J, Schniewind SI, Schwarz F, Dubrovska A. Cancer stem cells in head and neck squamous cell carcinoma: identification, characterization and clinical implications. Cancers. 2019;11(5):616.","journal-title":"Cancers"},{"key":"3981_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112616","volume":"147","author":"T Zhang","year":"2022","unstructured":"Zhang T, Zhou H, Wang K, Wang X, Wang M, Zhao W, et al. Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development. Biomed Pharmacother. 2022;147:112616.","journal-title":"Biomed Pharmacother"},{"key":"3981_CR212","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-025-00908-4","author":"S Sulaiman","year":"2025","unstructured":"Sulaiman S, Alaarag A, Rayyan N, Tuffaha Y, Al-Awamleh N, Al Dojan KA. Advancing toward a curative frontier: an updated narrative review on stem-cell therapy in pediatric type 1 diabetes. World J Pediatr. 2025. https:\/\/doi.org\/10.1007\/s12519-025-00908-4.","journal-title":"World J Pediatr"},{"issue":"2","key":"3981_CR213","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021109221","volume":"41","author":"R Vegliante","year":"2022","unstructured":"Vegliante R, Pastushenko I, Blanpain C. Deciphering functional tumor states at single-cell resolution. EMBO J. 2022;41(2):e109221.","journal-title":"EMBO J"},{"issue":"2","key":"3981_CR214","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s13402-022-00760-y","volume":"46","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wu T, Wang Y, Chen Z, Chen J, Lu S, et al. Reciprocal FGF19-GLI2 signaling induces epithelial-to-mesenchymal transition to promote lung squamous cell carcinoma metastasis. Cell Oncol. 2023;46(2):437\u201350.","journal-title":"Cell Oncol"},{"issue":"1","key":"3981_CR215","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00491-w","volume":"6","author":"Z Wang","year":"2021","unstructured":"Wang Z, Zhang H, Xu S, Liu Z, Cheng Q. The adaptive transition of glioblastoma stem cells and its implications on treatments. Signal Transduct Target Ther. 2021;6(1):124.","journal-title":"Signal Transduct Target Ther"},{"key":"3981_CR216","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.701291","volume":"11","author":"X Tang","year":"2021","unstructured":"Tang X, Zuo C, Fang P, Liu G, Qiu Y, Huang Y, et al. Targeting glioblastoma stem cells: a review on biomarkers, signal pathways and targeted therapy. Front Oncol. 2021;11:701291.","journal-title":"Front Oncol"},{"key":"3981_CR217","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01189-3","volume":"19","author":"J Cheng","year":"2020","unstructured":"Cheng J, Meng J, Zhu L, Peng Y. Exosomal noncoding RNAs in glioma: biological functions and potential clinical applications. Mol Cancer. 2020;19:1\u201314.","journal-title":"Mol Cancer"},{"issue":"12","key":"3981_CR218","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1101\/gad.261982.115","volume":"29","author":"JD Lathia","year":"2015","unstructured":"Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CL, Rich JN. Cancer stem cells in glioblastoma. Genes Dev. 2015;29(12):1203\u201317.","journal-title":"Genes Dev"},{"issue":"1","key":"3981_CR219","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00600-2","volume":"8","author":"Indira Chandran V","year":"2024","unstructured":"Chandran V Indira, Gopala S, Venkat EH, Kjolby M, Nejsum P. Extracellular vesicles in glioblastoma: a challenge and an opportunity. NPJ Precis Oncol. 2024;8(1):103.","journal-title":"NPJ Precis Oncol"},{"issue":"2","key":"3981_CR220","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1158\/2159-8290.CD-20-1848","volume":"12","author":"Z Qiu","year":"2022","unstructured":"Qiu Z, Zhao L, Shen JZ, Liang Z, Wu Q, Yang K, et al. Transcription elongation machinery is a druggable dependency and potentiates immunotherapy in glioblastoma stem cells. Cancer Discov. 2022;12(2):502\u201321.","journal-title":"Cancer Discov"},{"key":"3981_CR221","first-page":"128","volume":"7","author":"BJ Wilson","year":"2011","unstructured":"Wilson BJ, Schatton T, Frank MH, Frank NY. Colorectal cancer stem cells: biology and therapeutic implications. Curr Colorectal Cancer Rep. 2011;7:128\u201335.","journal-title":"Curr Colorectal Cancer Rep"},{"issue":"1","key":"3981_CR222","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01556-2","volume":"21","author":"H Zhou","year":"2022","unstructured":"Zhou H, Zhu L, Song J, Wang G, Li P, Li W, et al. Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer. Mol Cancer. 2022;21(1):86.","journal-title":"Mol Cancer"},{"issue":"6","key":"3981_CR223","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.stem.2014.11.012","volume":"15","author":"A Zeuner","year":"2014","unstructured":"Zeuner A, Todaro M, Stassi G, De Maria R. Colorectal cancer stem cells: from the crypt to the clinic. Cell Stem Cell. 2014;15(6):692\u2013705.","journal-title":"Cell Stem Cell"},{"key":"3981_CR224","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1251561","volume":"13","author":"H Wang","year":"2023","unstructured":"Wang H, Zhang Z, Ruan S, Yan Q, Chen Y, Cui J, et al. Regulation of iron metabolism and ferroptosis in cancer stem cells. Front Oncol. 2023;13:1251561.","journal-title":"Front Oncol"},{"issue":"12","key":"3981_CR225","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.107098","volume":"49","author":"M Kemper","year":"2023","unstructured":"Kemper M, Melling N, Krause L, K\u00fchn K, Gra\u00df J-K, Izbicki JR, et al. Muscle quality, not quantity, is associated with outcome after colorectal cancer surgery. Eur J Surg Oncol. 2023;49(12):107098.","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"3981_CR226","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042290","volume":"23","author":"A Nowosad","year":"2022","unstructured":"Nowosad A, Besson A. Lysosomes at the crossroads of cell metabolism, cell cycle, and stemness. Int J Mol Sci. 2022;23(4):2290.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"3981_CR227","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1158\/1078-0432.CCR-14-1399","volume":"21","author":"M Cioffi","year":"2015","unstructured":"Cioffi M, Trabulo S, Hidalgo M, Costello E, Greenhalf W, Erkan M, et al. Inhibition of CD47 effectively targets pancreatic cancer stem cells via dual mechanisms. Clin Cancer Res. 2015;21(10):2325\u201337.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"3981_CR228","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1080\/15384101.2018.1489180","volume":"17","author":"Z Xu","year":"2018","unstructured":"Xu Z, Jia Y, Huang X, Feng N, Li Y. Rapid induction of pancreatic cancer cells to cancer stem cells via heterochromatin modulation. Cell Cycle. 2018;17(12):1487\u201395.","journal-title":"Cell Cycle"},{"issue":"38","key":"3981_CR229","doi-asserted-by":"publisher","first-page":"E8948","DOI":"10.1073\/pnas.1806219115","volume":"115","author":"L Li","year":"2018","unstructured":"Li L, Li J-C, Yang H, Zhang X, Liu L-L, Li Y, et al. Expansion of cancer stem cell pool initiates lung cancer recurrence before angiogenesis. Proc Natl Acad Sci U S A. 2018;115(38):E8948\u201357.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3981_CR230","doi-asserted-by":"crossref","unstructured":"Garg M. Understanding the autophagic functions in cancer stem cell maintenance and therapy resistance. Expert Reviews in Molecular Medicine. 2024;26:e23.","DOI":"10.1017\/erm.2024.23"},{"issue":"1","key":"3981_CR231","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01608-z","volume":"8","author":"V Panwar","year":"2023","unstructured":"Panwar V, Singh A, Bhatt M, Tonk RK, Azizov S, Raza AS, et al. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. Signal Transduct Target Ther. 2023;8(1):375.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"3981_CR232","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21113994","volume":"21","author":"K Yamazaki","year":"2020","unstructured":"Yamazaki K, Kawabori M, Seki T, Houkin K. Clinical trials of stem cell treatment for spinal cord injury. Int J Mol Sci. 2020;21(11):3994.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3981_CR233","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010062","volume":"15","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Mei Y, Wang Z, He W. The effect of oxidative phosphorylation on cancer drug resistance. Cancers. 2022;15(1):62.","journal-title":"Cancers"},{"key":"3981_CR234","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.572722","volume":"10","author":"R Xu","year":"2020","unstructured":"Xu R, Yang J, Ren B, Wang H, Yang G, Chen Y, et al. Reprogramming of amino acid metabolism in pancreatic cancer: recent advances and therapeutic strategies. Front Oncol. 2020;10:572722.","journal-title":"Front Oncol"},{"issue":"3","key":"3981_CR235","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nbt.1607","volume":"28","author":"Y Saito","year":"2010","unstructured":"Saito Y, Uchida N, Tanaka S, Suzuki N, Tomizawa-Murasawa M, Sone A, et al. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Nat Biotechnol. 2010;28(3):275\u201380.","journal-title":"Nat Biotechnol"},{"issue":"11","key":"3981_CR236","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/nbt1350","volume":"25","author":"F Ishikawa","year":"2007","unstructured":"Ishikawa F, Yoshida S, Saito Y, Hijikata A, Kitamura H, Tanaka S, et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol. 2007;25(11):1315\u201321.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"3981_CR237","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-021-00253-w","volume":"9","author":"SB Panina","year":"2021","unstructured":"Panina SB, Pei J, Kirienko NV. Mitochondrial metabolism as a target for acute myeloid leukemia treatment. Cancer Metab. 2021;9(1):17.","journal-title":"Cancer Metab"},{"issue":"12","key":"3981_CR238","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","volume":"24","author":"DA Pollyea","year":"2018","unstructured":"Pollyea DA, Stevens BM, Jones CL, Winters A, Pei S, Minhajuddin M, et al. Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia. Nat Med. 2018;24(12):1859\u201366.","journal-title":"Nat Med"},{"issue":"9","key":"3981_CR239","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1158\/2159-8290.CD-22-1297","volume":"13","author":"S Pei","year":"2023","unstructured":"Pei S, Shelton IT, Gillen AE, Stevens BM, Gasparetto M, Wang Y, et al. A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy. Cancer Discov. 2023;13(9):2032\u201349.","journal-title":"Cancer Discov"},{"issue":"14","key":"3981_CR240","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411697","volume":"24","author":"Y Matsumoto","year":"2023","unstructured":"Matsumoto Y, Fukui T, Horitani S, Tanimura Y, Suzuki R, Tomiyama T, et al. A short-term model of colitis-associated colorectal cancer that suggests initial tumor development and the characteristics of cancer stem cells. Int J Mol Sci. 2023;24(14):11697.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3981_CR241","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cell.2013.02.021","volume":"153","author":"L Cheng","year":"2013","unstructured":"Cheng L, Huang Z, Zhou W, Wu Q, Donnola S, Liu JK, et al. Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cell. 2013;153(1):139\u201352.","journal-title":"Cell"},{"issue":"656","key":"3981_CR242","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn1128","volume":"14","author":"C Chen","year":"2022","unstructured":"Chen C, Jing W, Chen Y, Wang G, Abdalla M, Gao L, et al. Intracavity generation of glioma stem cell\u2013specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy. Sci Transl Med. 2022;14(656):eabn1128.","journal-title":"Sci Transl Med"},{"issue":"8","key":"3981_CR243","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22084011","volume":"22","author":"B Chen","year":"2021","unstructured":"Chen B, McCuaig-Walton D, Tan S, Montgomery AP, Day BW, Kassiou M, et al. DYRK1A negatively regulates CDK5-SOX2 pathway and self-renewal of glioblastoma stem cells. Int J Mol Sci. 2021;22(8):4011.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3981_CR244","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","volume":"12","author":"N Takebe","year":"2015","unstructured":"Takebe N, Miele L, Harris PJ, Jeong W, Bando H, Kahn M, et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol. 2015;12(8):445\u201364.","journal-title":"Nat Rev Clin Oncol"},{"key":"3981_CR245","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101234","author":"R Tang","year":"2023","unstructured":"Tang R, Xu J, Wang W, Meng Q, Shao C, Zhang Y, et al. Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response. Cell Rep Med. 2023. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101234.","journal-title":"Cell Rep Med"},{"issue":"9","key":"3981_CR246","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23092193","volume":"23","author":"S Palomeras","year":"2018","unstructured":"Palomeras S, Ruiz-Mart\u00ednez S, Puig T. Targeting breast cancer stem cells to overcome treatment resistance. Molecules. 2018;23(9):2193.","journal-title":"Molecules"},{"issue":"1","key":"3981_CR247","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2174\/2468187310666191223141038","volume":"10","author":"M Kumar","year":"2020","unstructured":"Kumar M, Rajnikanth P. A mini-review on HER2 positive breast cancer and its metastasis:resistance and treatment strategies. Curr Nanomed. 2020;10(1):36\u201347.","journal-title":"Curr Nanomed"},{"issue":"1","key":"3981_CR248","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-024-00659-x","volume":"10","author":"S Shen","year":"2024","unstructured":"Shen S, Salehi E, White C, Chen Y, Iyengar NM. Evaluation of a mobile behavior change program for weight loss in breast cancer survivors. NPJ Breast Cancer. 2024;10(1):53.","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"3981_CR249","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00422-8","volume":"7","author":"H Lyu","year":"2023","unstructured":"Lyu H, Hou D, Liu H, Ruan S, Tan C, Wu J, et al. HER3 targeting augments the efficacy of panobinostat in claudin-low triple-negative breast cancer cells. NPJ Precis Oncol. 2023;7(1):72.","journal-title":"NPJ Precis Oncol"},{"key":"3981_CR250","doi-asserted-by":"crossref","unstructured":"Lee JE, Lim JH, Hong YK, Yang SH. High-dose metformin plus temozolomide shows increased anti-tumor effects in glioblastoma in vitro and in vivo compared with monotherapy.Cancer research and treatment: official journal of Korean Cancer Association. 2018;50(4):1331-42.","DOI":"10.4143\/crt.2017.466"},{"key":"3981_CR251","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.688027","volume":"11","author":"J Qin","year":"2021","unstructured":"Qin J, Jiang C, Cai J, Meng X. Roles of long noncoding RNAs in conferring glioma progression and treatment. Front Oncol. 2021;11:688027.","journal-title":"Front Oncol"},{"issue":"4","key":"3981_CR252","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1158\/2159-8290.CD-22-0455","volume":"13","author":"Z Ye","year":"2023","unstructured":"Ye Z, Ai X, Yang K, Yang Z, Fei F, Liao X, et al. Targeting microglial metabolic rewiring synergizes with immune-checkpoint blockade therapy for glioblastoma. Cancer Discov. 2023;13(4):974\u20131001.","journal-title":"Cancer Discov"},{"issue":"7647","key":"3981_CR253","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nature21713","volume":"543","author":"F de Sousa e Melo","year":"2017","unstructured":"de Sousa e Melo F, Kurtova AV, Harnoss JM, Kljavin N, Hoeck JD, Hung J, et al. A distinct role for Lgr5\u2009+\u2009stem cells in primary and metastatic colon cancer. Nature. 2017;543(7647):676\u201380.","journal-title":"Nature"},{"key":"3981_CR254","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19224","author":"H Gao","year":"2023","unstructured":"Gao H, Ma L, Zou Q, Hu B, Cai K, Sun Y, et al. Unraveling dynamic interactions between tumor-associated macrophages and consensus molecular subtypes in colorectal cancer: an integrative analysis of single-cell and bulk RNA transcriptome. Heliyon. 2023. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19224.","journal-title":"Heliyon"},{"issue":"4","key":"3981_CR255","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1080\/0284186X.2020.1725240","volume":"59","author":"BD Vermeulen","year":"2020","unstructured":"Vermeulen BD, Bruggeman L, Bac DJ, Schrauwen RW, Epping LS, Scheffer RC, et al. Impact of multidisciplinary tumor board discussion on palliation of patients with esophageal or gastro-esophageal junction cancer: a population-based study. Acta Oncol. 2020;59(4):410\u20136.","journal-title":"Acta Oncol"},{"issue":"6","key":"3981_CR256","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1158\/1078-0432.CCR-17-2994","volume":"24","author":"KL Aung","year":"2018","unstructured":"Aung KL, Fischer SE, Denroche RE, Jang G-H, Dodd A, Creighton S, et al. Genomics-driven precision medicine for advanced pancreatic cancer: early results from the COMPASS trial. Clin Cancer Res. 2018;24(6):1344\u201354.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3981_CR257","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S2468-1253(23)00240-6","volume":"9","author":"L Valle","year":"2024","unstructured":"Valle L, Monahan KJ. Genetic predisposition to gastrointestinal polyposis: syndromes, tumour features, genetic testing, and clinical management. Lancet Gastroenterol Hepatol. 2024;9(1):68\u201382.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"27","key":"3981_CR258","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.3748\/wjg.v28.i27.3297","volume":"28","author":"C Smith","year":"2022","unstructured":"Smith C, Zheng W, Dong J, Wang Y, Lai J, Liu X, et al. Tumor microenvironment in pancreatic ductal adenocarcinoma: implications in immunotherapy. World J Gastroenterol. 2022;28(27):3297.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"3981_CR259","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.21037\/tcr-24-201","volume":"13","author":"W Zheng","year":"2024","unstructured":"Zheng W, Yu W, Hua R, He J, Wu N, Tian S, et al. Systematic analysis of TREM2 and its carcinogenesis in pancreatic cancer. Transl Cancer Res. 2024;13(7):3200.","journal-title":"Transl Cancer Res"},{"key":"3981_CR260","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1372330","volume":"12","author":"H Su","year":"2024","unstructured":"Su H, Peng C, Liu Y. Regulation of ferroptosis by PI3K\/Akt signaling pathway: a promising therapeutic axis in cancer. Front Cell Dev Biol. 2024;12:1372330.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"3981_CR261","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14364-2","volume":"7","author":"W Li","year":"2017","unstructured":"Li W, Ma H, Zhang J, Zhu L, Wang C, Yang Y. Unraveling the roles of CD44\/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis. Sci Rep. 2017;7(1):13856.","journal-title":"Sci Rep"},{"key":"3981_CR262","doi-asserted-by":"crossref","unstructured":"Pei S, Pollyea DA, Gustafson A, Stevens BM, Minhajuddin M, Fu R, et al. Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia. Cancer discovery. 2020;10(4):536\u2009\u2013\u200951.","DOI":"10.1158\/2159-8290.CD-19-0710"},{"issue":"1","key":"3981_CR263","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1182\/asheducation-2011.1.354","volume":"2011","author":"KM Bernt","year":"2011","unstructured":"Bernt KM, Armstrong SA. Targeting epigenetic programs in MLL-rearranged leukemias. Hematology. 2011;2011(1):354\u201360.","journal-title":"Hematology"},{"key":"3981_CR264","doi-asserted-by":"publisher","DOI":"10.1002\/INMD.20240131","author":"J Zhao","year":"2025","unstructured":"Zhao J, Cui J, Wang L, Shi X, Ding J, Sohail MF, et al. Nanomaterials for acute myeloid leukemia therapy: current progress and future perspectives. Interdiscip Med. 2025. https:\/\/doi.org\/10.1002\/INMD.20240131.","journal-title":"Interdiscip Med"},{"key":"3981_CR265","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.107066","volume":"161","author":"S Guo","year":"2023","unstructured":"Guo S, Liu X, Zhang J, Huang Z, Ye P, Shi J, et al. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels T cell-related prognostic risk model and tumor immune microenvironment modulation in triple-negative breast cancer. Comput Biol Med. 2023;161:107066.","journal-title":"Comput Biol Med"},{"issue":"9","key":"3981_CR266","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Al-Eryani G, Roden DL, Junankar S, Harvey K, Andersson A, et al. A single-cell and spatially resolved atlas of human breast cancers. Nat Genet. 2021;53(9):1334\u201347.","journal-title":"Nat Genet"},{"issue":"1","key":"3981_CR267","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1073\/pnas.1815345116","volume":"116","author":"F Bocci","year":"2019","unstructured":"Bocci F, Gearhart-Serna L, Boareto M, Ribeiro M, Ben-Jacob E, Devi GR, et al. Toward understanding cancer stem cell heterogeneity in the tumor microenvironment. Proc Natl Acad Sci U S A. 2019;116(1):148\u201357.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3981_CR268","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00564-3","volume":"8","author":"G Fan","year":"2024","unstructured":"Fan G, Xie T, Li L, Tang L, Han X, Shi Y. Single-cell and spatial analyses revealed the co-location of cancer stem cells and SPP1\u2009+\u2009macrophage in hypoxic region that determines the poor prognosis in hepatocellular carcinoma. NPJ Precis Oncol. 2024;8(1):75.","journal-title":"NPJ Precis Oncol"},{"key":"3981_CR269","doi-asserted-by":"crossref","unstructured":"Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, et al. An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell. 2019;178(4):835\u2009\u2013\u200949.e21.","DOI":"10.1016\/j.cell.2019.06.024"},{"issue":"19","key":"3981_CR270","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019104063","volume":"39","author":"SZ Wu","year":"2020","unstructured":"Wu SZ, Roden DL, Wang C, Holliday H, Harvey K, Cazet AS, et al. Stromal cell diversity associated with immune evasion in human triple-negative breast cancer. EMBO J. 2020;39(19):e104063.","journal-title":"EMBO J"},{"issue":"7","key":"3981_CR271","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26072933","volume":"26","author":"J Wu","year":"2025","unstructured":"Wu J, Liu X, Huang S, Liu W. Identification of a cancer stem cell-related gene signature in hepatocellular carcinoma based on single-cell RNA-seq and bulk RNA-seq analysis. Int J Mol Sci. 2025;26(7):2933.","journal-title":"Int J Mol Sci"},{"key":"3981_CR272","unstructured":"Li R, Liu X, Huang X, Zhang D, Chen Z, Zhang J, et al. Single-cell transcriptomic analysis deciphers heterogenous cancer stem-like cells in colorectal cancer and their organ-specific metastasis. Gut. 2024;73(3):470\u2009\u2013\u200984."},{"issue":"1","key":"3981_CR273","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15146","volume":"8","author":"J Li","year":"2017","unstructured":"Li J, Yu B, Deng P, Cheng Y, Yu Y, Kevork K, et al. KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt\/\u03b2-catenin signalling. Nat Commun. 2017;8(1):15146.","journal-title":"Nat Commun"},{"issue":"8","key":"3981_CR274","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada E, Bolisetty M, Laise P, Flynn WF, Courtois ET, Burkhart RA, et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov. 2019;9(8):1102\u201323.","journal-title":"Cancer Discov"},{"issue":"1","key":"3981_CR275","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16164-1","volume":"11","author":"N Kim","year":"2020","unstructured":"Kim N, Kim HK, Lee K, Hong Y, Cho JH, Choi JW, et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat Commun. 2020;11(1):2285.","journal-title":"Nat Commun"},{"issue":"4","key":"3981_CR276","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/ncb2717","volume":"15","author":"JP Medema","year":"2013","unstructured":"Medema JP. Cancer stem cells: the challenges ahead. Nat Cell Biol. 2013;15(4):338\u201344.","journal-title":"Nat Cell Biol"},{"issue":"7222","key":"3981_CR277","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nature07567","volume":"456","author":"E Quintana","year":"2008","unstructured":"Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. Efficient tumour formation by single human melanoma cells. Nature. 2008;456(7222):593\u20138.","journal-title":"Nature"},{"issue":"4","key":"3981_CR278","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc1590","volume":"5","author":"M Dean","year":"2005","unstructured":"Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer. 2005;5(4):275\u201384.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"3981_CR279","first-page":"e700","volume":"4","author":"L Li","year":"2024","unstructured":"Li L, Sun Y. Challenges and advances of immune checkpoint therapy. Clin Transl Discov. 2024;4(6):e700-01.","journal-title":"Clin Transl Discov"},{"key":"3981_CR280","doi-asserted-by":"crossref","unstructured":"Song Y, Lei L, Cai X, Wei H, Yu CY. Immunomodulatory Peptides for Tumor Treatment.Advanced Healthcare Materials. 2024:2400512.","DOI":"10.1002\/adhm.202400512"},{"issue":"9","key":"3981_CR281","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12092158","volume":"12","author":"R Ghemrawi","year":"2024","unstructured":"Ghemrawi R, Abuamer L, Kremesh S, Hussien G, Ahmed R, Mousa W, et al. Revolutionizing cancer treatment: recent advances in immunotherapy. Biomedicines. 2024;12(9):2158.","journal-title":"Biomedicines"},{"issue":"17\u201318","key":"3981_CR282","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.drudis.2012.05.010","volume":"17","author":"P Parhi","year":"2012","unstructured":"Parhi P, Mohanty C, Sahoo SK. Nanotechnology-based combinational drug delivery: An emerging approach for cancer therapy. Drug Discov Today. 2012;17(17\u201318):1044\u201352.","journal-title":"Drug Discov Today"},{"issue":"10","key":"3981_CR283","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.2217\/nnm.12.128","volume":"7","author":"G Mattheolabakis","year":"2012","unstructured":"Mattheolabakis G, Rigas B, Constantinides PP. Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectives. Nanomedicine. 2012;7(10):1577\u201390.","journal-title":"Nanomedicine"},{"issue":"11","key":"3981_CR284","first-page":"5975","volume":"37","author":"BN Ho","year":"2017","unstructured":"Ho BN, Pfeffer CM, Singh AT. Update on nanotechnology-based drug delivery systems in cancer treatment. Anticancer Res. 2017;37(11):5975\u201381.","journal-title":"Anticancer Res"},{"key":"3981_CR285","doi-asserted-by":"crossref","unstructured":"Jabir NR, Tabrez S, Ashraf GM, Shakil S, Damanhouri GA, Kamal MA. Nanotechnology-based approaches in anticancer research. International journal of nanomedicine. 2012:4391\u2009\u2013\u2009408.","DOI":"10.2147\/IJN.S33838"},{"issue":"1","key":"3981_CR286","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02214-5","volume":"24","author":"M Wang","year":"2025","unstructured":"Wang M, Yu F, Zhang Y. Present and future of cancer nano-immunotherapy: opportunities,obstacles and challenges. Mol Cancer. 2025;24(1):26.","journal-title":"Mol Cancer"},{"key":"3981_CR287","doi-asserted-by":"crossref","unstructured":"Verma M, Sheoran P, Chaudhury A. Application of nanotechnology for cancer treatment.Advances in animal biotechnology and its applications. 2018:161\u2009\u2013\u200978.","DOI":"10.1007\/978-981-10-4702-2_10"},{"issue":"1","key":"3981_CR288","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jpm2010001","volume":"2","author":"M Verma","year":"2012","unstructured":"Verma M. Personalized medicine and cancer. J Pers Med. 2012;2(1):1\u201314.","journal-title":"J Pers Med"},{"key":"3981_CR289","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pharmthera.2018.02.001","volume":"187","author":"S Annett","year":"2018","unstructured":"Annett S, Robson T. Targeting cancer stem cells in the clinic: current status and perspectives. Pharmacol Ther. 2018;187:13\u201330.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"3981_CR290","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/stmcls\/sxad092","volume":"42","author":"A Philchenkov","year":"2024","unstructured":"Philchenkov A, Dubrovska A. Cancer stem cells as a therapeutic target: current clinical development and future prospective. Stem Cells. 2024;42(3):173\u201399.","journal-title":"Stem Cells"},{"issue":"3","key":"3981_CR291","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7030066","volume":"7","author":"L Drago","year":"2019","unstructured":"Drago L. Probiotics and colon cancer. Microorganisms. 2019;7(3):66.","journal-title":"Microorganisms"},{"issue":"1","key":"3981_CR292","volume":"2019","author":"RL Bighetti-Trevisan","year":"2019","unstructured":"Bighetti-Trevisan RL, Sousa LO, Castilho RM, Almeida LO. Cancer stem cells: powerful targets to improve current anticancer therapeutics. Stem Cells Int. 2019;2019(1):9618065.","journal-title":"Stem Cells Int"},{"issue":"1","key":"3981_CR293","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01808-1","volume":"9","author":"Y Xia","year":"2024","unstructured":"Xia Y, Sun M, Huang H, Jin W-L. Drug repurposing for cancer therapy. Signal Transduct Target Ther. 2024;9(1):92.","journal-title":"Signal Transduct Target Ther"},{"key":"3981_CR294","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.861959","volume":"12","author":"W Guo","year":"2022","unstructured":"Guo W, Du K, Luo S, Hu D. Recent advances of autophagy in non-small cell lung cancer: from basic mechanisms to clinical application. Front Oncol. 2022;12:861959.","journal-title":"Front Oncol"},{"key":"3981_CR295","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.pharmthera.2018.06.007","volume":"191","author":"J Pelt","year":"2018","unstructured":"Pelt J, Busatto S, Ferrari M, Thompson EA, Mody K, Wolfram J. Chloroquine and nanoparticle drug delivery: a promising combination. Pharmacol Ther. 2018;191:43\u20139.","journal-title":"Pharmacol Ther"},{"issue":"49","key":"3981_CR296","doi-asserted-by":"publisher","first-page":"6299","DOI":"10.1038\/s41388-018-0370-5","volume":"37","author":"L Shi","year":"2018","unstructured":"Shi L, Tang X, Qian M, Liu Z, Meng F, Fu L, et al. A SIRT1-centered circuitry regulates breast cancer stemness and metastasis. Oncogene. 2018;37(49):6299\u2013315.","journal-title":"Oncogene"},{"issue":"443","key":"3981_CR297","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aah6816","volume":"10","author":"Y Shi","year":"2018","unstructured":"Shi Y, Guryanova OA, Zhou W, Liu C, Huang Z, Fang X, et al. Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance. Sci Transl Med. 2018;10(443):eaah6816.","journal-title":"Sci Transl Med"},{"issue":"2","key":"3981_CR298","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020945","volume":"25","author":"NI Agalakova","year":"2024","unstructured":"Agalakova NI. Chloroquine and chemotherapeutic compounds in experimental cancer treatment. Int J Mol Sci. 2024;25(2):945.","journal-title":"Int J Mol Sci"},{"issue":"16","key":"3981_CR299","doi-asserted-by":"publisher","first-page":"14005","DOI":"10.18632\/oncotarget.4159","volume":"6","author":"R Lamb","year":"2015","unstructured":"Lamb R, Fiorillo M, Chadwick A, Ozsvari B, Reeves KJ, Smith DL, et al. Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: implications for more effective radiation therapy. Oncotarget. 2015;6(16):14005.","journal-title":"Oncotarget"},{"issue":"40","key":"3981_CR300","doi-asserted-by":"publisher","first-page":"67269","DOI":"10.18632\/oncotarget.18428","volume":"8","author":"EM De Francesco","year":"2017","unstructured":"De Francesco EM, Bonuccelli G, Maggiolini M, Sotgia F, Lisanti MP. Vitamin C and doxycycline: a synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs). Oncotarget. 2017;8(40):67269.","journal-title":"Oncotarget"},{"issue":"9","key":"3981_CR301","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1038\/s41418-021-00788-x","volume":"28","author":"M Fiorillo","year":"2021","unstructured":"Fiorillo M, Scatena C, Naccarato AG, Sotgia F, Lisanti MP. Bedaquiline, an FDA-approved drug, inhibits mitochondrial ATP production and metastasis in vivo, by targeting the gamma subunit (ATP5F1C) of the ATP synthase. Cell Death Differ. 2021;28(9):2797\u2013817.","journal-title":"Cell Death Differ"},{"issue":"3","key":"3981_CR302","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030418","volume":"13","author":"Y Lu","year":"2021","unstructured":"Lu Y, Zhu Y, Deng S, Chen Y, Li W, Sun J, et al. Targeting the sonic hedgehog pathway to suppress the expression of the cancer stem cell (Csc)\u2014related transcription factors and csc-driven thyroid tumor growth. Cancers (Basel). 2021;13(3):418.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"3981_CR303","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061481","volume":"9","author":"C Zhou","year":"2020","unstructured":"Zhou C, Fan N, Liu F, Fang N, Plum PS, Thieme R, et al. Linking cancer stem cell plasticity to therapeutic resistance-mechanism and novel therapeutic strategies in esophageal cancer. Cells. 2020;9(6):1481.","journal-title":"Cells"},{"key":"3981_CR304","doi-asserted-by":"crossref","unstructured":"Reisenauer KN, Aroujo J, Tao Y, Ranganathan S, Romo D, Taube JH. Therapeutic vulnerabilities of cancer stem cells and effects of natural products. Natural product reports. 2023;40(8):1432-56.","DOI":"10.1039\/D3NP00002H"},{"issue":"01","key":"3981_CR305","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1142\/S0192415X24500071","volume":"52","author":"Y Wang","year":"2024","unstructured":"Wang Y, Yuan X, Ren M, Wang Z. Ferroptosis: a new research direction of Artemisinin and its derivatives in anti-cancer treatment. Am J Chin Med. 2024;52(01):161\u201381.","journal-title":"Am J Chin Med"},{"key":"3981_CR306","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.104105","volume":"190","author":"Y Li","year":"2023","unstructured":"Li Y, Tuerxun H, Liu X, Zhao Y, Wen S, Li Y, et al. Nrf2\u2013a hidden bridge linking cancer stem cells to ferroptosis. Critical Reviews in Oncology\/Hematology. 2023;190:104105.","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"5","key":"3981_CR307","first-page":"613","volume":"17","author":"C Qiao","year":"2022","unstructured":"Qiao C, Wang H, Guan Q, Wei M, Li Z. Ferroptosis-based nano delivery systems targeted therapy for colorectal cancer: insights and future perspectives. Asian J Pharm Sci. 2022;17(5):613\u201329.","journal-title":"Asian J Pharm Sci"},{"key":"3981_CR308","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101085","volume":"26","author":"Y Chen","year":"2024","unstructured":"Chen Y, Li X, Luo K, Wang T, Liu T, Lu E, et al. Hyperthermia\/glutathione-triggered ferritin nanoparticles amplify the ferroptosis for synergistic tumor therapy. Mater Today Bio. 2024;26:101085.","journal-title":"Mater Today Bio"},{"issue":"1","key":"3981_CR309","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02909-3","volume":"22","author":"Y Li","year":"2024","unstructured":"Li Y, Chen J, Xia Q, Shang J, He Y, Li Z, et al. Photothermal Fe3O4 nanoparticles induced immunogenic ferroptosis for synergistic colorectal cancer therapy. J Nanobiotechnology. 2024;22(1):630.","journal-title":"J Nanobiotechnology"},{"key":"3981_CR310","doi-asserted-by":"crossref","unstructured":"Espinoza I, Pochampally R, Xing F, Watabe K, Miele L. Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition. OncoTargets and therapy.2013:1249-59.","DOI":"10.2147\/OTT.S36162"},{"issue":"7","key":"3981_CR311","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4252\/wjsc.v11.i7.398","volume":"11","author":"F-Y Du","year":"2019","unstructured":"Du F-Y, Zhou Q-F, Sun W-J, Chen G-L. Targeting cancer stem cells in drug discovery: current state and future perspectives. World J Stem Cells. 2019;11(7):398.","journal-title":"World J Stem Cells"},{"key":"3981_CR312","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2023.107291","volume":"182","author":"S Bhalla","year":"2023","unstructured":"Bhalla S, Fattah FJ, Ahn C, Williams J, Macchiaroli A, Padro J, et al. Phase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancer. Lung Cancer. 2023;182:107291.","journal-title":"Lung Cancer"},{"issue":"8","key":"3981_CR313","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1080\/15384047.2019.1599660","volume":"20","author":"R Gupta","year":"2019","unstructured":"Gupta R, Bhatt LK, Johnston TP, Prabhavalkar KS. Colon cancer stem cells: potential target for the treatment of colorectal cancer. Cancer Biol Ther. 2019;20(8):1068\u201382.","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"3981_CR314","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","volume":"138","author":"PB Gupta","year":"2009","unstructured":"Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 2009;138(4):645\u201359.","journal-title":"Cell"},{"issue":"7","key":"3981_CR315","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-023-02062-1","volume":"40","author":"R Serttas","year":"2023","unstructured":"Serttas R, Erdogan S. Pretreatment of prostate cancer cells with salinomycin and Wnt inhibitor increases the efficacy of cabazitaxel by inducing apoptosis and decreasing cancer stem cells. Med Oncol. 2023;40(7):194.","journal-title":"Med Oncol"},{"issue":"1","key":"3981_CR316","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2024.2393442","volume":"13","author":"K Kainulainen","year":"2024","unstructured":"Kainulainen K, Niskanen EA, Kinnunen J, M\u00e4ki-Mantila K, Hartikainen K, Paakinaho V, et al. Secreted factors from M1 macrophages drive prostate cancer stem cell plasticity by upregulating NANOG, SOX2, and CD44 through NF\u03baB-signaling. Oncoimmunology. 2024;13(1):2393442.","journal-title":"Oncoimmunology"},{"key":"3981_CR317","doi-asserted-by":"crossref","unstructured":"Hirsch HA, Iliopoulos D, Tsichlis PN, Struhl K. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer research. 2009;69(19):7507-11.","DOI":"10.1158\/0008-5472.CAN-09-2994"},{"key":"3981_CR318","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2020.106383","volume":"94","author":"T Saito","year":"2020","unstructured":"Saito T, Itoh M, Tohda S. Metformin suppresses the growth of leukemia cells partly through downregulation of AXL receptor tyrosine kinase. Leuk Res. 2020;94:106383.","journal-title":"Leuk Res"},{"issue":"1","key":"3981_CR319","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10549-023-07241-2","volume":"205","author":"H Johansson","year":"2024","unstructured":"Johansson H, Bellerba F, Macis D, Bertelsen B-E, Guerrieri-Gonzaga A, Aristarco V, et al. Effect of metformin and lifestyle intervention on adipokines and hormones in breast cancer survivors: a pooled analysis from two randomized controlled trials. Breast Cancer Res Treat. 2024;205(1):49\u201359.","journal-title":"Breast Cancer Res Treat"},{"issue":"39","key":"3981_CR320","doi-asserted-by":"publisher","first-page":"41944","DOI":"10.18632\/oncotarget.5986","volume":"6","author":"L-L Bu","year":"2015","unstructured":"Bu L-L, Zhao Z-L, Liu J-F, Ma S-R, Huang C-F, Liu B, et al. STAT3 blockade enhances the efficacy of conventional chemotherapeutic agents by eradicating head neck stemloid cancer cell. Oncotarget. 2015;6(39):41944.","journal-title":"Oncotarget"},{"issue":"7684","key":"3981_CR321","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nature25016","volume":"552","author":"Z Skrott","year":"2017","unstructured":"Skrott Z, Mistrik M, Andersen KK, Friis S, Majera D, Gursky J, et al. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. Nature. 2017;552(7684):194\u20139.","journal-title":"Nature"},{"issue":"3","key":"3981_CR322","doi-asserted-by":"publisher","first-page":"6579","DOI":"10.1080\/21655979.2022.2038434","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Guan X, Wang M, Wang N, Chen Y, Li B, et al. Disulfiram\/Copper induces antitumor activity against gastric cancer via the ROS\/MAPK and NPL4 pathways. Bioengineered. 2022;13(3):6579\u201389.","journal-title":"Bioengineered"},{"key":"3981_CR323","doi-asserted-by":"crossref","unstructured":"Liu Y, Liu X, Pan C. Advances in Factors Affecting ALDH2 Activity and its Mechanisms.Cardiovascular Toxicology. 2024;24(12):1428-38.","DOI":"10.1007\/s12012-024-09923-9"},{"key":"3981_CR324","unstructured":"Affolter A, Lammert A, Kern J, Scherl C, Rotter N. Stem Cell-Based Approaches in. Advancement in Cancer Stem Cell Biology and Precision Medicine. 2022:744969044."},{"key":"3981_CR325","unstructured":"Arner EN. Deciphering AXL-Driven Molecular Mechanisms of EMT 2021."},{"issue":"4","key":"3981_CR326","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1158\/0008-5472.CAN-09-2997","volume":"70","author":"SJ Holland","year":"2010","unstructured":"Holland SJ, Pan A, Franci C, Hu Y, Chang B, Li W, et al. R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer. Cancer Res. 2010;70(4):1544\u201354.","journal-title":"Cancer Res"},{"key":"3981_CR327","doi-asserted-by":"crossref","unstructured":"Falade AS, Adeoye O, Van Loon K, Buckle GC. Clinical Trials in Gastroesophageal Cancers: An Analysis of the Global Landscape of Interventional Trials From ClinicalTrials.gov. JCO Global Oncology. 2024;10:e2400169.","DOI":"10.1200\/GO.24.00169"},{"key":"3981_CR328","doi-asserted-by":"crossref","unstructured":"Bekaii-Saab T, Okusaka T, Goldstein D, Oh D, Ueno M, Ioka T, et al. 1466P Napabucasin\u2009+\u2009nab-paclitaxel with gemcitabine in patients (pts) with metastatic pancreatic adenocarcinoma (mPDAC):results from the phase III CanStem111P study. Annals of Oncology. 2021;32:S1084-S5.","DOI":"10.1016\/j.annonc.2021.08.794"},{"issue":"1","key":"3981_CR329","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines7010017","volume":"7","author":"MB Sonbol","year":"2019","unstructured":"Sonbol MB, Ahn DH, Bekaii-Saab T. Therapeutic targeting strategies of cancer stem cells in gastrointestinal malignancies. Biomedicines. 2019;7(1):17.","journal-title":"Biomedicines"},{"key":"3981_CR330","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116685","volume":"175","author":"L Sun","year":"2024","unstructured":"Sun L, Xing J, Zhou X, Song X, Gao S. Wnt\/\u03b2-catenin signalling, epithelial-mesenchymal transition and crosslink signalling in colorectal cancer cells. Biomed Pharmacother. 2024;175:116685.","journal-title":"Biomed Pharmacother"},{"key":"3981_CR331","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00614","volume":"8","author":"Y He","year":"2018","unstructured":"He Y, Li W, Hu G, Sun H, Kong Q. Bioactivities of EF24, a novel curcumin analog: a review. Front Oncol. 2018;8:614.","journal-title":"Front Oncol"},{"issue":"9","key":"3981_CR332","doi-asserted-by":"publisher","first-page":"12441","DOI":"10.1007\/s13277-016-5123-x","volume":"37","author":"EA Elghonaimy","year":"2016","unstructured":"Elghonaimy EA, Ibrahim SA, Youns A, Hussein Z, Nouh MA, El-Mamlouk T, et al. Secretome of tumor-associated leukocytes augment epithelial-mesenchymal transition in positive lymph node breast cancer patients via activation of EGFR\/Tyr845 and NF-\u03baB\/p65 signaling pathway. Tumor Biol. 2016;37(9):12441\u201353.","journal-title":"Tumor Biol"},{"issue":"6","key":"3981_CR333","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1248\/bpb.b23-00103","volume":"46","author":"T MaruYama","year":"2023","unstructured":"MaruYama T, Yamakoshi H, Iwabuchi Y, Shibata H. Mono-carbonyl curcumin analogs for cancer therapy. Biol Pharm Bull. 2023;46(6):756\u201363.","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"3981_CR334","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2023.2205042","volume":"38","author":"ST Boateng","year":"2023","unstructured":"Boateng ST, Roy T, Torrey K, Owunna U, Banang-Mbeumi S, Basnet D, et al. Synthesis, in silico modelling, and in vitro biological evaluation of substituted pyrazole derivatives as potential anti-skin cancer, anti-tyrosinase, and antioxidant agents. J Enzyme Inhib Med Chem. 2023;38(1):2205042.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"7","key":"3981_CR335","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15071936","volume":"15","author":"R Wedam","year":"2023","unstructured":"Wedam R, Greer YE, Wisniewski DJ, Weltz S, Kundu M, Voeller D, et al. Targeting mitochondria with ClpP agonists as a novel therapeutic opportunity in breast cancer. Cancers. 2023;15(7):1936.","journal-title":"Cancers"},{"issue":"10","key":"3981_CR336","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102400","volume":"13","author":"JM Przystal","year":"2021","unstructured":"Przystal JM, Becker H, Canjuga D, Tsiami F, Anderle N, Keller A-L, et al. Targeting CSF1R alone or in combination with PD1 in experimental glioma. Cancers. 2021;13(10):2400.","journal-title":"Cancers"},{"key":"3981_CR337","doi-asserted-by":"crossref","unstructured":"Maru S, Matthias MD, Kuwatsuru R, Simpson Jr RJ. Studies of Artificial Intelligence\/Machine Learning Registered on ClinicalTrials. gov: Cross-Sectional Study With Temporal Trends,2010\u20132023. Journal of Medical Internet Research. 2024;26:e57750.","DOI":"10.2196\/57750"},{"issue":"8","key":"3981_CR338","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1158\/0008-5472.CAN-15-2162","volume":"76","author":"JKT Dermawan","year":"2016","unstructured":"Dermawan JKT, Hitomi M, Silver DJ, Wu Q, Sandlesh P, Sloan AE, et al. Pharmacological targeting of the histone chaperone complex FACT preferentially eliminates glioblastoma stem cells and prolongs survival in preclinical models. Cancer Res. 2016;76(8):2432\u201342.","journal-title":"Cancer Res"},{"issue":"7","key":"3981_CR339","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1007\/s13346-023-01505-6","volume":"14","author":"Y Xu","year":"2024","unstructured":"Xu Y, Qiu Z, Chen J, Huang L, Zhang J, Lin J. LINC00460 promotes neuroblastoma tumorigenesis and cisplatin resistance by targeting miR-149-5p\/DLL1 axis and activating Notch pathway in vitro and in vivo. Drug Deliv Transl Res. 2024;14(7):2003\u201318.","journal-title":"Drug Deliv Transl Res"},{"key":"3981_CR340","doi-asserted-by":"crossref","unstructured":"Isakova AA, Druzhkova IN, Mozherov AM, Mazur DV, Antipova NV, Krasnov KS, et al. Glioblastoma Sensitization to Therapeutic Effects by Glutamine Deprivation Depends on Cellular Phenotype and Metabolism. Biochemistry (Moscow). 2024;89(10):1744-58.","DOI":"10.1134\/S0006297924100079"},{"key":"3981_CR341","doi-asserted-by":"crossref","unstructured":"Mir GJ, Manzoor I, Islam Au, Ganie SA, Hamid R. Cancer Stem Cells as Promising Nanotherapeutic Targets. Personalized and Precision Nanomedicine for Cancer Treatment:Springer; 2024. p. 27\u201368.","DOI":"10.1007\/978-981-97-3545-7_4"},{"issue":"10","key":"3981_CR342","first-page":"4637","volume":"12","author":"J-M Li","year":"2022","unstructured":"Li J-M, Hsu P-C, Kuan F-C, Shi C-S, Yang C-T. The cancer stemness inhibitor napabucasin suppresses small cell lung cancer growth through SOX2 expression. Am J Cancer Res. 2022;12(10):4637.","journal-title":"Am J Cancer Res"},{"issue":"3","key":"3981_CR343","doi-asserted-by":"publisher","first-page":"e194489","DOI":"10.1001\/jamaoncol.2019.4489","volume":"6","author":"MB Sonbol","year":"2020","unstructured":"Sonbol MB, Mountjoy LJ, Firwana B, Liu AJ, Almader-Douglas D, Mody K, et al. The role of maintenance strategies in metastatic colorectal cancer: a systematic review and network meta-analysis of randomized clinical trials. JAMA Oncol. 2020;6(3):e194489-e.","journal-title":"JAMA Oncol"},{"key":"3981_CR344","volume":"29","author":"J Wang","year":"2018","unstructured":"Wang J, Liu S, Uronis H, Wu C, Mahalingam D, Spira A, et al. Novel small-molecule ROR\u03b3 agonist immuno-oncology agent LYC-55716: safety and efficacy in a phase IIA open-label,multicenter trial. Ann Oncol. 2018;29:viii404-viii5.","journal-title":"Ann Oncol"},{"issue":"3","key":"3981_CR345","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/13543784.2022.2037552","volume":"31","author":"K Dorman","year":"2022","unstructured":"Dorman K, Heinemann V, Kobold S, Von Bergwelt-Baildon M, Boeck S. Novel systemic treatment approaches for metastatic pancreatic cancer. Expert Opin Investig Drugs. 2022;31(3):249\u201362.","journal-title":"Expert Opin Investig Drugs"},{"issue":"24","key":"3981_CR346","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246228","volume":"13","author":"S Parakh","year":"2021","unstructured":"Parakh S, Ernst M, Poh AR. Multicellular effects of STAT3 in non-small cell lung cancer: mechanistic insights and therapeutic opportunities. Cancers. 2021;13(24):6228.","journal-title":"Cancers"},{"key":"3981_CR347","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00404","volume":"9","author":"V Kumar","year":"2018","unstructured":"Kumar V, Soni P, Garg M, Kamholz S, Chandra AB. Emerging therapies in the management of advanced-stage gastric cancer. Front Pharmacol. 2018;9:404.","journal-title":"Front Pharmacol"},{"issue":"15","key":"3981_CR348","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512520","volume":"24","author":"JA Park","year":"2023","unstructured":"Park JA, Cheung N-KV. Promise and challenges of T cell immunotherapy for osteosarcoma. Int J Mol Sci. 2023;24(15):12520.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3981_CR349","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1053\/j.gastro.2020.04.077","volume":"159","author":"DM Chopyk","year":"2020","unstructured":"Chopyk DM, Grakoui A. Contribution of the intestinal microbiome and gut barrier to hepatic disorders. Gastroenterology. 2020;159(3):849\u201363.","journal-title":"Gastroenterology"},{"key":"3981_CR350","doi-asserted-by":"crossref","unstructured":"Jung K-W, Won Y-J, Hong S, Kong H-J, Lee ES. Prediction of cancer incidence and mortality in Korea, 2020. Cancer Research and Treatment: Official Journal of Korean Cancer Association. 2020;52(2):351-8.","DOI":"10.4143\/crt.2020.203"},{"issue":"1","key":"3981_CR351","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02239-1","volume":"10","author":"A-B Tigu","year":"2024","unstructured":"Tigu A-B, Munteanu R, Moldovan C, Rares D, Kegyes D, Tomai R, et al. Therapeutic advances in the targeting of ROR1 in hematological cancers. Cell Death Discov. 2024;10(1):471.","journal-title":"Cell Death Discov"},{"issue":"2","key":"3981_CR352","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiae141","volume":"117","author":"J Wang","year":"2025","unstructured":"Wang J, Li Z, Zhao Q. Receptor tyrosine kinase-like orphan receptor serves as a potential target in cancer immunotherapy. J Leukoc Biol. 2025;117(2):qiae141.","journal-title":"J Leukoc Biol"},{"issue":"3","key":"3981_CR353","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/bjc.2014.608","volume":"112","author":"K Choi","year":"2015","unstructured":"Choi K, Jun J, Suh M, Park B, Noh D, Song S, et al. Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening Programme in Korea. Br J Cancer. 2015;112(3):608\u201312.","journal-title":"Br J Cancer"},{"issue":"7","key":"3981_CR354","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41573-021-00189-2","volume":"20","author":"AJ Hou","year":"2021","unstructured":"Hou AJ, Chen LC, Chen YY. Navigating CAR-T cells through the solid-tumour microenvironment. Nat Rev Drug Discov. 2021;20(7):531\u201350.","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"3981_CR355","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1080\/13543784.2024.2348068","volume":"33","author":"J Gao","year":"2024","unstructured":"Gao J, Cheng J, Xie W, Zhang P, Liu X, Wang Z, et al. Prospects of focal adhesion kinase inhibitors as a cancer therapy in preclinical and early phase study. Expert Opin Investig Drugs. 2024;33(6):639\u201351.","journal-title":"Expert Opin Investig Drugs"},{"issue":"9","key":"3981_CR356","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nrc3792","volume":"14","author":"FJ Sulzmaier","year":"2014","unstructured":"Sulzmaier FJ, Jean C, Schlaepfer DD. FAK in cancer: mechanistic findings and clinical applications. Nat Rev Cancer. 2014;14(9):598\u2013610.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"3981_CR357","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s43018-019-0020-z","volume":"1","author":"CA Stewart","year":"2020","unstructured":"Stewart CA, Gay CM, Xi Y, Sivajothi S, Sivakamasundari V, Fujimoto J, et al. Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer. Nat Cancer. 2020;1(4):423\u201336.","journal-title":"Nat Cancer"},{"key":"3981_CR358","doi-asserted-by":"crossref","unstructured":"Gagan N, Sanand S, editors. Enhancing Oncology Care With Federated Learning and Foundation Models. 2024 ITU Kaleidoscope: Innovation and Digital Transformation for a Sustainable World (ITU K); 2024: IEEE.","DOI":"10.23919\/ITUK62727.2024.10772940"},{"issue":"2","key":"3981_CR359","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1158\/0008-5472.CAN-14-1223","volume":"75","author":"VN Kolev","year":"2015","unstructured":"Kolev VN, Wright QG, Vidal CM, Ring JE, Shapiro IM, Ricono J, et al. PI3K\/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells. Cancer Res. 2015;75(2):446\u201355.","journal-title":"Cancer Res"},{"key":"3981_CR360","unstructured":"Montero Mart\u00edn S. Nanotechnology-mediated strategies targeting cancer stem cells for advanced cancer treatment. 2021."},{"issue":"1","key":"3981_CR361","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02153-x","volume":"21","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Liu M, Long W, Yuan J, Li H, Zhang C, et al. Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma. Cancer Cell Int. 2021;21(1):456.","journal-title":"Cancer Cell Int"},{"key":"3981_CR362","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.154010","volume":"237","author":"M Ebrahimi","year":"2022","unstructured":"Ebrahimi M, Nourbakhsh E, Hazara AZ, Mirzaei A, Shafieyari S, Salehi A, et al. PI3K\/Akt\/mTOR signaling pathway in cancer stem cells. Pathology-Research and Practice. 2022;237:154010.","journal-title":"Pathology-Research and Practice"},{"key":"3981_CR363","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673345472250301052255","author":"S Abdullaeva","year":"2025","unstructured":"Abdullaeva S, Abdullaeva P, Gabdrahimova R, Nazmieva K, Neganova ME, Liu J, et al. Analysis of the main directions in the development of mono and combination pharmacotherapy acting on hormonal signaling pathways of breast cancer according to the FDA databases and clinicaltrials. gov. Curr Med Chem. 2025. https:\/\/doi.org\/10.2174\/0109298673345472250301052255.","journal-title":"Curr Med Chem"},{"issue":"3","key":"3981_CR364","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002068","volume":"9","author":"D Melisi","year":"2021","unstructured":"Melisi D, Oh D-Y, Hollebecque A, Calvo E, Varghese A, Borazanci E, et al. Safety and activity of the TGF\u03b2 receptor i kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer. J Immunother Cancer. 2021;9(3):e002068.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"3981_CR365","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1158\/1535-7163.MCT-17-0070","volume":"17","author":"SK Misra","year":"2018","unstructured":"Misra SK, De A, Pan D. Targeted delivery of STAT-3 modulator to breast cancer stem-like cells downregulates a series of stemness genes. Mol Cancer Ther. 2018;17(1):119\u201329.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"3981_CR366","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00430-1","volume":"6","author":"H-M Zhou","year":"2021","unstructured":"Zhou H-M, Zhang J-G, Zhang X, Li Q. Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents. Signal Transduct Target Ther. 2021;6(1):62.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3981_CR367","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010616","volume":"25","author":"Y-H Huang","year":"2024","unstructured":"Huang Y-H, Chiu L-Y, Tseng J-S, Hsu K-H, Chen C-H, Sheu G-T, et al. Attenuation of PI3K-Akt-mTOR pathway to reduce cancer stemness on chemoresistant lung cancer cells by shikonin and synergy with BEZ235 inhibitor. Int J Mol Sci. 2024;25(1):616.","journal-title":"Int J Mol Sci"},{"key":"3981_CR368","doi-asserted-by":"crossref","unstructured":"Kang Z, Li S, Li Y, Song J, Peng Y, Chen Y. Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: An updated review (from 2022 to 2024). Chinese Chemical Letters. 2024:110447.","DOI":"10.1016\/j.cclet.2024.110447"},{"issue":"8","key":"3981_CR369","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1001\/jamaoncol.2017.0184","volume":"3","author":"N Ahmed","year":"2017","unstructured":"Ahmed N, Brawley V, Hegde M, Bielamowicz K, Kalra M, Landi D, et al. HER2-specific chimeric antigen receptor\u2013modified virus-specific T cells for progressive glioblastoma: a phase 1 dose-escalation trial. JAMA Oncol. 2017;3(8):1094\u2013101.","journal-title":"JAMA Oncol"},{"issue":"4","key":"3981_CR370","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1158\/1078-0432.CCR-21-2867","volume":"28","author":"JL Hu","year":"2022","unstructured":"Hu JL, Omofoye OA, Rudnick JD, Kim S, Tighiouart M, Phuphanich S, et al. A phase I study of autologous dendritic cell vaccine pulsed with allogeneic stem-like cell line lysate in patients with newly diagnosed or recurrent glioblastoma. Clin Cancer Res. 2022;28(4):689\u201396.","journal-title":"Clin Cancer Res"},{"key":"3981_CR371","doi-asserted-by":"crossref","unstructured":"Moore AR, Rosenberg SC, McCormick F, Malek S. RAS-targeted therapies: is the undruggable drugged? Nature reviews Drug discovery. 2020;19(8):533\u2009\u2013\u200952.","DOI":"10.1038\/s41573-020-0068-6"},{"key":"3981_CR372","unstructured":"Clarke H. Differences in health care access may drive prostate cancer disparities.Urology Times. 2023;51(12):31\u2009\u2013\u20092."},{"issue":"43","key":"3981_CR373","doi-asserted-by":"publisher","first-page":"75756","DOI":"10.18632\/oncotarget.20798","volume":"8","author":"C-L Zhang","year":"2017","unstructured":"Zhang C-L, Huang T, Wu B-L, He W-X, Liu D. Stem cells in cancer therapy: opportunities and challenges. Oncotarget. 2017;8(43):75756.","journal-title":"Oncotarget"},{"issue":"5","key":"3981_CR374","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nmeth.4258","volume":"14","author":"S Shukla","year":"2017","unstructured":"Shukla S, Langley MA, Singh J, Edgar JM, Mohtashami M, Z\u00fa\u00f1iga-Pfl\u00fccker JC, et al. Progenitor T-cell differentiation from hematopoietic stem cells using Delta-like-4 and VCAM-1. Nat Methods. 2017;14(5):531\u20138.","journal-title":"Nat Methods"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03981-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-03981-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03981-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:06:50Z","timestamp":1761696410000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-03981-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":374,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3981"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-03981-x","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The available literature is succinctly reviewed in this work. There was no need for ethical approval or participant informed consent because this review article is based on published data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"380"}}